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ABSTRACT OF THE DISSERTATION 
Delayed Onset Muscle Soreness in People with Diabetes; Biomarkers 
and Nutritional Supplementation 
 
by 
Hani H. Al-Nakhli 
Doctor of Philosophy, Graduate Program in Rehabilitation Science 
Loma Linda University, December 2011 
Dr. Jerrold Petrofsky, Chairperson 
 
Exercise is important for controlling hemoglobin A1c, and maintaining proper 
glycemic control in people with diabetes. Exercise also increases the diabetics overall 
insulin sensitivity, and decreases their dependency on diabetes medication. However, 
people with diabetes are faced with metabolic and endothelial impairment, which could 
result in a prolonged sensation of muscle soreness following exercise. This would make it 
difficult for these people to sustain exercise regimes. Delayed-onset muscle soreness 
(DOMS) is a common problem in healthy individuals and in people who have diabetes. 
DOMS is a painful sensation experienced by individuals who have been recently inactive 
and then over-exercise.  
Yet, because people with diabetes usually have neuropathies, they may not feel 
this soreness appropriately, leading to premature return to exercise and causing further 
injuries. Therefore, this investigation assessed the differences in DOMS between people 
with diabetes, and healthy individuals, at 2 different body regions. However, DOMS is 
mainly measured with subjective scales, but we wanted to establish a new objective 
measure. Infra-red (IR) thermal imaging was used as one of the biomarkers in this 
assessment, and after expanding on this technique, it was considered a valid and relaible 
xiv 
tool for detecting and quantifying delayed onset muscle soreness after an intense exercise 
session. 
Once muscle soreness in people with diabetes was determined, and a new novel 
biomarker was established, another focus of this dissertation was to examine whether 
DOMS could be attenuated by ingesting a nutritional supplement. Branched Chain 
Amino Acids (BCAA) have been shown to be effective in promoting muscle recovery 
following exercise; however, the effects of this supplement have not been investigated 
amongst diabetic individuals.  
The results of this experiment showed that people with diabetes get sorer than 
healthy individuals. It was also found that IR thermal imaging may be a valuable 
technique for identifying which muscles are sore after exercising. Thus, thermal imaging 
would be an efficient and painless way of quantifying DOMS in both healthy individuals 
and in people with diabetes. Furthermore, this investigation showed that BCAA 
significantly reduced muscle soreness and enhanced healing in subjects with diabetes. 
However, in the healthy control group this supplement had minimal effects. 
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CHAPTER ONE 
INTRODUCTION 
 
Diabetes and Exercise 
The diabetes epidemic is on the rise in both developing and developed countries. 
1,2 According to the World Health Organization (WHO) and recent estimates, the disease 
now affects approximately 345 million people worldwide and is expected to affect around 
440 million by 2030, representing almost 8% of the global adult population. 3,4 Also, the 
International Diabetes Federation (IDF) determined that Type 2 diabetes mellitus 
(T2DM) accounts for almost 90% of all diabetes cases. 5 
Lifestyle characteristics such as obesity, a sedentary lifestyle, and lack of physical 
activity are regarded as the most important risk factors, both independently associated 
with diabetes and diabetes related co-morbidities. 6,7 Co-morbidities associated with 
diabetes are considered an even bigger concern than being diagnosed with the disease 
itself. This is because diabetes has been ranked one of the leading causes of death by 
disease; 8 the WHO has estimated that deaths from diabetes will almost double between 
2005 and 2030. 9 
Exercise is considered a major cornerstone of diabetes management. Studies have 
verified the usefulness of exercise as part of the treatment and prevention of T2DM. 6,10,11 
Even though aerobic exercise has beneficial effects for managing and treating T2DM, it 
has been found that resistance-type exercise is also effective in controlling blood glucose, 
and in reducing Hemoglobin A1c (HbA1c). 10,12-14 It would actually be more beneficial 
2 
for individuals with diabetes to participate in a combination of both aerobic and 
resistance exercises to properly manage their blood glucose. A combined exercise 
program has been shown to have more pronounced effects on glycemic control, muscle 
strength, and insulin sensitivity. 10,12,15 An important finding in a study done by Church 
and colleagues 12 showed that a combination training group decreased their diabetes 
medication dependency, when compared to a control group who had increased their use 
of diabetes medications. It would be imperative then to include resistance training as a 
primary step in the exercise schedule of a diabetic patient. This is particularly important 
for obese individuals who have been inactive for a while, since they face the challenge of 
participating in aerobic exercises due to their low fitness levels. 
Resistance training then, would be better for individuals with diabetes to begin 
with, as it contributes to the recruitment of previously inactive muscle fibers. This has 
been found to enhance the quality of the muscle, which eventually leads to a substantial 
gain in muscle mass. 10,16,17 As a result, the body’s insulin sensitivity will be amplified 
and glucose tolerance levels improved, thereby improving the body’s glucose disposal 
capacity and giving the diabetic individual a better chance to cope with the disease. 6,10,16 
 
Delayed Onset Muscle Soreness 
People with or without diabetes might get discouraged from exercising because of 
the related soreness. This type of soreness is called delayed onset muscle soreness 
(DOMS), and is a typical phenomenon that occurs in skeletal muscle as a result of novel 
or unaccustomed exercise. 18-20 The severity of the damage and the extent of discomfort is 
exacerbated over time, and occurs minutes to days after an acute exercise bout. 18,19 The 
3 
intensity of the symptoms and discomfort associated with DOMS usually peaks between 
24 to 72 hours post exercise, and can last for up to 10 days, especially when the exercise 
bout encompasses an eccentric component. 20-22 Activities that are comprised of repeated 
eccentric contractions have been shown to result in damage to the ultrastructure of 
skeletal muscle. 23,24 This damage manifests itself as a temporary decrease in muscle 
function, restricted range of motion in the associated joint, increased muscle soreness, 
and swelling of the involved muscle group. 23,25,26 Consequently, DOMS is considered 
one of the most common recurrent forms of injury, which can lead to further injuries if a 
premature return to exercise is attempted. 19 
The DOMS phenomenon has gained a considerable amount of interest lately, 
particularly amongst researchers and specialists in exercise physiology, sports, and 
rehabilitation. 27 However, DOMS has not been investigated in people with diabetes, and 
being able to objectively determine the extent of soreness using a reliable biomarker is 
sometimes a challenge. 
 
Biomarkers and Thermal Imaging 
 DOMS is not an easy pathology to quantify, as there is a wide amount of 
variability between the measurement tools and methods used to quantify this condition. 27 
No agreement has been made on one best evaluation measure for DOMS, which makes it 
difficult to identify the impact of a specific intervention in decreasing the symptoms 
associated with DOMS. Even though needle biopsies of the muscle and blood levels of 
myofiber proteins might be considered a gold standard, 27 large variations in some of 
these blood proteins have been documented. 27,28 There are also high risks sometimes 
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associated with invasive techniques. Thus, it can be seen that muscle soreness, especially 
in diabetic individuals who have neuropathies is somewhat ambiguous, because many 
studies depend on measuring soreness using a subjective visual analog scale (VAS). 29-33 
Muscle soreness has various underlying mechanisms, but a main mechanism of 
soreness is related to blood flow and inflammation in the muscle. 19,34 Thus, when there is 
damage to the muscle, the blood flow should increase because of the inflammatory 
process, which results in the increase of the skin temperature above it. Infrared (IR) 
thermography has been used, and found to be successful in detecting different types of 
diseases and infections since the 1950’s. 35 There is ample evidence for this phenomenon. 
For example, a common technique for detecting some types of tumors is by using 
thermography. 36-39 In many cases, the tumor has higher blood flows than the rest of the 
examined area, which warms up a spot under the skin and shows up on a thermal image. 
36-39 Consequently, a muscle that is sore should also show up on a thermal image because 
of this same phenomenon. The advantage of thermal imaging is that it would provide 
useful information relative to the damage in the muscle, unlike subjective pain 
measurements which can be altered by the individual’s sensation of pain and the 
associated neuropathies from diabetes. Therefore, a noninvasive technique that detects 
DOMS in its early stages would be very beneficial for this population, as it could prevent 
them from premature return to exercise, thus decreasing the risks of further injuries. 
On the other hand, people with diabetes might not be getting enough nutrients, 
vitamins, and amino acids from their diets, due to the fact that they have gastrointestinal 
and mal-absorption problems. 40-42 Interestingly, some studies have suggested that 
nutritional supplementation after exercising can reduce or even prevent DOMS. 
5 
Nutritional Supplementation and Amino Acids 
Amino acids are the molecular building blocks from which proteins are made. 
There are essential and nonessential amino acids, and the difference between them is that 
the human body can synthesize the nonessential amino acids, but the essential amino 
acids (EAA) have to be taken through our diets. 43 Resistance exercise causes decreases 
of some of the EAA, including branched chain amino acids (BCAA), during the recovery 
period after exercise. 44,45 Skeletal muscle however, remains in an overall catabolic state 
unless muscle protein synthesis surpasses muscle protein breakdown, and for this to take 
place, adequate nutritional intervention is necessary during this recovery period. 46,47 
Thus, when EAA are ingested in conjunction with an acute bout of resistance training, the 
hypertrophic response is enhanced, resulting in a net increase in muscle protein synthesis. 
25,48 
Among these EAA, exceptional results have been observed with BCAA. 48,49 
Studies have indicated that BCAA are mainly taken up by active skeletal muscles during 
sub-maximal exercise, whereas all other amino acids are taken up by the liver. 44,50 Thus, 
the metabolism of BCAA is initiated in skeletal muscle, and the oxidation process is 
enhanced by exercise. Numerous studies have investigated the effects of BCAA 
supplementation on skeletal muscle soreness, where some studies found that BCAA may 
be useful for muscle recovery following acute sessions of exercise, both in trained and 
untrained individuals. 25,26,47,51,52 However, nutritional supplementation and its effects on 
muscle soreness has not been examined in people with diabetes. 
 
 
6 
Approach of Studies 
To study DOMS in people with diabetes, it is necessary to establish whether 
people with diabetes experience similar levels of soreness as healthy individuals or not? 
This question arises because it is known that people with diabetes have neuropathies, and 
with neuropathies they tend to have hypo or hyper-sensitivity. 53 Also, people with 
diabetes have high levels of free radicals and chronic inflammation, which could prolong 
muscle healing, and make it harder for these people to properly workout. 53,54 Therefore, 
in chapter 2 of this dissertation, the problem of DOMS was examined in people with and 
without diabetes to see if muscle soreness after exercising was greater or less between 
them. We looked at DOMS in diabetic and healthy individuals at different areas of the 
body, and used a thermal imaging technique in addition to other biomarkers to quantify 
muscle soreness. As an outcome of the first study, in chapter 3 we expanded on this new 
thermal imaging technique and clarified how it can be used as a reliable biomarker to 
measure DOMS. An objective measure to determine and quantify muscle soreness is 
critical, because subjectively, two people could portray the same level of soreness 
whereas in reality they are experiencing different pain symptoms after performing a 
similar exercise. Once this new measuring technique was validated, in chapter 4 we used 
it in addition to other biomarkers to confirm if DOMS could be reduced with a nutritional 
supplement in people with diabetes. In this investigation our supplement of choice was 
BCAA, because there is abundant evidence suggesting that protein supplements which 
are high in BCAA can attenuate muscle damage, and reduce muscle soreness. 25,26,55 
 
 
7 
Investigation Purposes 
The purpose of this investigation was three fold: 
 First, to identify whether people with diabetes become as sore, or sorer than 
healthy individuals after an intense exercise session, as there are hardly any studies that 
look at DOMS in people with diabetes.  
 Second, to look at biomarkers of muscle soreness, and establish a new objective 
means of quantifying muscle soreness. In this case, it was measuring skin temperature 
using thermal imaging, as there are no published studies done on DOMS and changes in 
skin temperatures. 
 Third, to verify whether nutritional supplementation could reduce muscle 
soreness and increase healing in people with diabetes. In this investigation, our focus was 
on BCAA, as no study to date has assessed the effectiveness of a BCAA supplement on 
DOMS in a diabetic population. 
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Abstract 
Background: Exercise is of great value for individuals with diabetes in helping to 
control their HbA1c levels, and increasing their insulin sensitivity. Delayed onset muscle 
soreness (DOMS) is a common problem in healthy individuals, and in people who have 
diabetes. People with diabetes are also faced with metabolic and endothelial impairments, 
which could make DOMS even worse. But because they usually have neuropathies, they 
may not feel this soreness appropriately, leading to premature return to exercise and 
causing further injuries. 
Research Design: 118 subjects participated in this study, and were divided into 4 
groups. Two groups (healthy, and diabetic) performed a series of abdominal exercises, 
and the other 2 groups (healthy, and diabetic) performed a series of arm exercises to 
induce DOMS. Skin temperature above the muscle was assessed using a thermal infra-red 
camera, and perceived soreness of the exercised muscle was assessed using a 100mm 
visual analog scale (VAS). Serum myoglobin concentrations were also measured. 
Results: the results showed that there was a significant increase in skin 
temperature 24 hours post exercise for all 4 exercised groups (P < 0.05), where the 
combined average increase in skin temperature for all 4 groups was approximately 0.65 
°C from baseline. Also, 24 hours post-exercise, all 4 groups were significantly sorer than 
they were at baseline (P < 0.05). Serum myoglobin levels were also significantly higher 
on day 3 when compared to day 1 (P < 0.05). 
Conclusion: Infra Red Thermal Imaging may be a valuable technique of seeing 
which muscles are sore hours or even days after the exercise is over. Thus, thermal 
imaging would be an efficient and painless way of looking at DOMS in both healthy 
10 
individuals, and individuals who have diabetes, even if they are facing neurological 
problems. 
 
Keywords: Diabetes, Muscle Soreness, DOMS, Thermal Imaging  
 
Introduction 
Exercise is recommended as part of the treatment and prevention of diabetes. 1,2 
The combination of both aerobic and resistance exercises have been found to be more 
effective in controlling blood glucose, and Hemoglobin A1c levels (HbA1c) when 
compared to only one type of exercise. 1,3 It is imperative to include resistance training as 
a primary step in the exercise schedule of a diabetic patient, since some face the 
challenge of participating in aerobic exercise due to their low fitness levels. Also, muscle 
building exercises are critical for the diabetic population, as an increase in the skeletal 
muscle mass has been associated with better insulin sensitivity in people who have 
diabetes. 4 But beginning with a resistive exercise routine after being physically inactive 
for prolonged periods of time, could cause delayed onset muscle soreness (DOMS). 5-7 
This would have the effect of reducing the individual’s willingness to continue 
exercising. 
While much is known about DOMS in young people, little is known about DOMS 
in people with diabetes. However, there may be some comparisons that can be made from 
studies of DOMS and ageing. 8 Studies have shown that there is reduced proteolytic 
activity and an elevated production in free radicals in older individuals. 8,9 This elevation 
prolongs healing time after excessive exercise. 8 With metabolic impairments, endothelial 
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dysfunction, and higher levels of free radicals in people with diabetes 10,11 DOMS could 
be more severe and recovery periods longer in this population. 
DOMS generally presents itself as initial soreness that starts within 24 hours of 
heavy exercise, where its associated symptoms can range from slight muscle tenderness 
to severe debilitating pain. 12-14 The severity of the symptoms depends on several factors 
including the fitness of the individual, their age, genetics, training, and the intensity of the 
activity. 15  The peak discomfort from muscle damage ranges between 24 to 72 hours 
post-exercise, but the symptoms may continue as much as 7 days post- exercise until they 
begin to diminish. 7,16 For this reason, DOMS is one of the most common recurrent forms 
of sports injury that can affect an individual’s performance, and become intimidating for 
many. 5,17 
For the last 3 decades, the DOMS phenomenon has gained a considerable amount 
of interest amongst researchers and specialists in exercise physiology, sports, and 
rehabilitation. 18 There has been a variety of published studies investigating this painful 
occurrence in regards to its underlying mechanisms, treatment interventions, and 
preventive strategies. 5-7,10,17,19-24 However, it is evident from the literature that DOMS is 
not an easy pathology to quantify, as there is a wide amount of variability between the 
measurement tools and methods used to quantify this condition. 18 It is obvious that no 
agreement has been made on one best evaluation measure for DOMS, which makes it 
difficult to verify whether a specific intervention really helps in decreasing the symptoms 
associated with this type of soreness. Even though needle biopsies of the muscle, and 
blood levels of myofibre proteins or myoglobin might be considered a gold standard to 
some, 18 large variations in some of these blood proteins have been documented. 18,25 
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Thus, it can be seen that muscle soreness is somewhat ambiguous, because many studies 
depend on measuring soreness using a visual analog scale (VAS). 22,26-29 But with people 
who have diabetes, they often have neuropathies, and in this case they might not be able 
to feel the muscle pain as well as normal individuals, therefore giving false VAS 
readings. 
Muscle soreness has a variety of underlying mechanisms, but a main mechanism 
of soreness is related to blood flow and inflammation in the muscle. 5,6 Thus, when there 
is damage to the muscle, the blood flow should increase due to the inflammatory process, 
which should result in the increase of the skin temperature above it. There is ample 
evidence for this phenomenon. For example, a common technique for detecting some 
types of tumors is by using thermography. 30-33 In many cases the tumor has higher blood 
flows than the rest of the examined area, which warms up a spot under the skin and 
shows up on a thermal image. 30-33 Consequently, a muscle that is sore should also show 
up on a thermal image due to this same phenomenon. The advantage of using thermal 
imaging is that, unlike subjective pain measurements which can be altered by the 
individuals sensation of pain, and the associated neuropathies from diabetes, thermal 
imaging would actually provide very useful information relative to the damage in the 
muscle. 
However, individuals with diabetes may have altered feeling of DOMS, or may 
not feel this type of muscle soreness due to their neuropathies. Therefore, a non invasive 
technique that could detect DOMS in its early stages would be very beneficial for this 
population, as it could prevent them from premature return to exercise. This may increase 
training and decrease their risks of injuries. It is surprising then that little has been done 
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on DOMS and changes in skin temperatures in this population. Therefore in the current 
study, we investigated changes in muscle soreness by looking at increases in skin 
temperatures using thermal imaging at 2 areas of the body. The first area was closer to 
the core of the body, and the second area was more peripheral, to see if we can detect a 
difference between the two regions. For the core area, the abdominal muscles were 
studied, as core muscles are usually warmer, and for the peripheral region, we examined 
the biceps muscle, because muscle and skin temperature in the peripheries are several 
degrees cooler than the core. Yet there have been no published studies looking at changes 
in skin temperature in individuals on days after they have done heavy exercise, to see if 
muscle soreness can be predicted by an increase in skin temperature. 
 
Subjects & Methods 
There were 118 subjects that participated in this study. Subjects were divided into 
2 basic groups, 1 group of 80 subjects that participated in an abdominal exercise, and 
another group of 38 subjects that participated in biceps exercise. These 2 groups were 
also subdivided into healthy subjects (no diabetes), and subjects with diabetes. All the 
subjects were physically inactive for at least 3 weeks. Subjects were excluded if they 
were pregnant, had hepatic diseases, were diagnosed with Rhabdomyolysis, were 
diagnosed with an impaired circulatory disease (such as Raynaud’s), had any recent 
upper limb or abdominal injuries, had severe neuropathies in their upper limbs, were 
hypertensive (blood pressure over 145/90 mmHg), or hypotensive (blood pressure lower 
than 90/50 mmHg), or were on high doses of alpha or beta agonist/antagonists, NSAID’s, 
Cox 2 inhibitors, Calcium channel blockers, Pregabalins, or Pain reducers. Some diabetic 
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subjects had minimal cardiovascular disease but were within the blood pressure ranges 
stated above and had no major complications. The average ages, heights, weights, and 
demographics of the subjects are shown in table 1. All subjects were informed of all 
experimental procedures and protocols and signed a statement of informed consent as 
approved by either the institutions review board at Azusa Pacific University or Loma 
Linda University. 
 
Table 1: General Characteristics of the Subjects (Means +/- SD)  
 
      N 
Age 
(Years) 
Height 
(CM) 
Weight 
(KG)  BMI  HbA1C 
Abdominal 
Exercise 
Healthy  40 
28.75 
(+/‐ 5.6) 
171.25 
(+/‐ 6.3) 
88.15 
(+/‐ 12.8) 
30.10 
(+/‐ 3.5) 
 
Diabetics  40 
59.0 
(+/‐ 9.9) 
176.08 
(+/‐6.9) 
95.95 
(+/‐ 14.6) 
31.43 
(+/‐ 4.9) 
7.7 
(+/‐ 1.9) 
Arm Biceps 
Exercise 
Healthy  22 
28.45 
(+/‐ 8.7) 
167.91 
(+/‐ 8.2) 
73.09 
(+/‐ 20.0) 
25.52 
(+/‐ 5.5) 
 
Diabetics  16 
61.25 
(+/‐ 12.6) 
167.56 
(+/‐ 14.8) 
109.25 
(+/‐ 39.6) 
38.07 
(+/‐ 10.2) 
7.1 
(+/‐ 1.7) 
  
 
The Exercise 
The group doing the arm exercise used a dumbbell to exercise one arm. The 
resistance used was different for each subject, and was determined by testing each 
participant for their resistance maximum (RM). To do this, we used a strength measuring 
device with 4 strain gauge arranged as a Wheatstone bridge. This was interfaced with a 
computer through a BioPac (DAC-100) bioelectric amplifier module (BioPac Systems, 
Goleta, CA). The module was connected to a BioPac MP-100 analog to digital converter 
sampling at a frequency of 1,000 hertz per second, and at a resolution of 24 bits. The 
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device was fixed to a bench at a 45° angle, so that the subject would not recruit any 
muscle other than the biceps. After determining the RM for the biceps muscle of each 
participant in that group, we made them sustain the intended session of exercise with 
35% of their RM calculated from the average of the 3 strength recordings done on the 
strain gauge device prior to the exercise. 
The abdominal group accomplished a number of exercises as shown in the P90X 
video series which is designed for both men and women (Beachbody LLC, Los Angeles, 
California, USA.).  The video includes several different exercise routines with various 
individuals doing each exercise differently, so the user could select low or high intensity 
variations of the exercise depending on their capability. For the purpose of this study, two 
workout videos were selected to emphasize the abdominal region. The first video, Core 
Synergistics lasted 44 minutes, followed by the Ab Ripper X video which lasted 16 
minutes, giving a 60-minute total workout. 
 
Skin Temperature 
 Skin temperature was measured using a Flir TC660 Thermal Camera (Stockholm, 
Sweden). The thermal image taken of the arm or abdominal regions were from 
approximately 1 meter away, and perpendicular to the skin (Fig. 1). From a series of tests 
done at our labs using the FLIR 660 IR Camera, this distance and angle were found to 
have the best correlation (r = 0.93) with thermocouple readings when compared to 
different distances from the skin (2, and 5 meters), and at different angles (15, 30, 45, and 
60 degrees). The images were taken in a temperature controlled room which was 
maintained at approximately 23°C (+/- 0.5°C). The temperatures from the acquired image 
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were measured at 4 locations on the skin above the biceps or abdominal muscle using the 
“ThermoVision® ExaminIR™” software Version: 1.10.2 (Fig. 2). These 4 readings were 
analyzed individually and then averaged to give a full perspective of the temperature 
above the exercised muscle. 
 
Soreness/Pain Visual Analog Scale 
A visual analog scale (VAS) was used to assess subjective soreness of the arm or 
abdominal muscles before doing the exercise and after the exercise was completed.  The 
scale had a 10 cm (100mm) long line marked “no pain” at one end, and “extremely sore” 
at the opposite end.  Each participant was directed to make a vertical mark along the 10 
cm line to indicate his or her response to soreness. 
 
 
 
Figure 1: The setup of the Infra Red camera 1 meter away from the skin, and 
perpendicular to the area being examined. 
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Figure 2: Software interface for the “ThermoVision® ExaminIR™” showing the 4 boxes 
of interest on an IR image of an exercised arm. Also shown are the statistical 
interpretations for each box from the software itself. 
 
 
Blood Sampling & Measurement of Myoglobin Concentrations 
 Approximately 4 ml peripheral blood was collected from an antecubital vein. 
Peripheral venous blood was drawn before (Pre), immediately after (Post), and 48 hours 
(2 days) after the exercise bout. The blood was spun down in a centrifuge at 4000 rpm for 
10 min to separate the serum from the cells. The samples were stored at -80°C until the 
analyses of myoglobin was done. 
Myoglobin was measured using a TOSOH “AIA®-360” Automated enzyme 
Immunoassay Analyzer (TOSOH Corp., Tokyo, Japan). The myoglobin Assay kits (Myo 
025297, ST AIA-PACK Myoglobin) were used according to the manufactures 
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instructions. Controls were run before and after each analyses session, to verify that the 
measurements were accurate and within the manufacturers specified quality control 
ranges. The normal reference range for myoglobin using this method was 31.4 - 971 
ng/ml. The intra-assay and inter-assay coefficient of variation was 2.76 %, and 4.45 % 
respectively. 
 
Procedure 
 In this investigation, we started off with the biceps study and monitored the 
soreness and heat variations for the subjects over a period of more than 3 days. It was 
realized that the biggest change in temperatures was at 24 hours. We then did the 
abdominal study for only 3 days, to see if the core muscles have the same heating 
response as the peripheral muscles. Blood samples for the myoglobin readings were only 
carried out on the arm group. Myoglobin measurements were not carried out on the 
abdominal group due to costs. 
After subjects attended to the fitness lab, baseline data, including a thermal image 
of the abdominal or arm muscles, and a soreness VAS reading were collected. Blood 
samples for the myoglobin analyses were also collected at this time, but only for the arm 
group. The targeted muscles for the subjects in the arm group were the elbow flexors. To 
provoke DOMS in these muscles, the subjects in this group carried out 4 sets of 25 
repetitions of biceps concentration curls while seated on a chair, and with the elbows 
supported on their thighs. Subjects were advised to lower the weight and lift it at a steady 
state (approximately 3 seconds going down, and 3 seconds coming back up), to insure 
that both the eccentric and concentric components of the contraction were properly done. 
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There was a 90 second resting period between each set and the other, and subjects either 
did the full set of 25 repetitions, or were instructed to stop the set if they failed to steadily 
control the descent of the weight and return their arm back to full flexion. As indicated 
previously, the resistance used was different for each subject, and was determined by 
testing each participant for their resistance maximum (RM). 
For the abdominal group, after the baseline readings, the subjects participated in 
the 60-minute workout video mentioned above, to induce DOMS in their abdominal 
muscles.  All subjects were asked to attempt the most difficult variation of each exercise, 
as they are able.  Subjects were given four 3-minute breaks throughout the video to rest. 
Subjects were told that they are allowed to stop the exercise at any time if it became too 
strenuous. 
Twenty-four hours post-exercise, thermal images of the arm or abdomen muscles 
were measured, and VAS readings were also taken at this time. Both these measures were 
also repeated at 48 hours post-exercise. Blood samples for the 2nd myoglobin reading 
were taken 30 minutes post-exercise, and the 3rd reading was taken 48 hours post-
exercise. 
 
Data Analysis 
Data analysis involved means, and standard deviations. Measurements of all 3 
variables (skin temperature, VAS, and myoglobin) were compared within each group 
using the repeated measures analysis of variance (ANOVA). Spearman’s correlation was 
also used to identify any relationships between the variables. Statistical analysis was 
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performed using PASW Statistics Version 18.0.0 (SPSS, Inc., 2009, Chicago, IL, 
www.spss.com), and the level of significance was set at P <0.05. 
 
Results 
Skin Temperature 
The results of the skin temperature measurements for the 4 groups are shown in 
figure 3. As seen in figure 3, all the 4 groups had increased skin temperatures 24 hours 
post exercise. For the healthy group who performed the P90x abdominal exercise, their 
average skin temperature for the measured area increased by 0.83° C, from 32.50 +/- 
0.37° C to 33.33 +/- 0.39° C. This increase in skin temperature was significant (P < 0.05). 
The increase in skin temperatures from baseline to 24 hours post exercise for the diabetic 
group who performed the P90x abdominal exercise was also significant (P < 0.05), where 
it increased by 0.61° C, from 33.02 +/- 0.16° C to 33.63 +/- 0.61°C. 
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Figure 3: A representative graph of the differences in skin temperatures measured with 
the thermal camera in the healthy group who performed the P90x Abdominal exercise 
(diamonds), the diabetic group who performed the P90x Abdominal exercise (squares), 
the healthy group who performed the arm exercise (triangles), and the diabetic group who 
performed the arm exercise (X), over the 3 day time period. 
 
For the groups that exercised their arm muscles, the healthy group had a 0.51° C 
increase in skin temperature between the first 2 days, from 32.4 +/- 0.87° C to 32.91 +/- 
0.96° C. This increase was significant (P < 0.05). Also, the diabetic group who exercised 
their arms had a significant increase in skin temperature (P < 0.05) from day 1 to day 2, 
where the increase was 0.62° C, from 32.58 +/- 0.85° C to 33.20 +/- 0.74° C (Fig. 4, A & 
B). 
By the 3rd day (48 hours post exercise), skin temperatures were almost back to 
normal, where there was no significant difference between day 1 (pre exercise) and day 3 
for all the groups (P > 0.05). 
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Figure 4: A) A thermal image of a diabetic individuals arm before exercising. B) A 
thermal image of the same individual’s arm 24 hours post exercise (the temperature of the 
arm jumped from 31.5 °C to 34.4 °C) 
 
 
Perceived Soreness (VAS) 
The results of the perceived muscle soreness are shown in figure 5. As seen in 
figure 5, all 4 groups had a dramatic increase in muscle soreness 24 hours post exercise. 
The healthy group, who performed the P90x abdominal exercise, had an increase of 
approximately 41.5 millimeters (mm) on the pain scale, from 0 pain to 41.5 +/- 6.1 mm. 
This increase was highly significant (P < 0.05). The diabetic group who performed the 
same abdominal exercise had an even higher increase in muscle soreness than the healthy 
subjects. Their baseline muscle soreness was 7.3 +/- 1.7 mm, which had increased to 73.8 
+/- 8.8 mm, 24 hours post exercise. That was a 66.5 mm increase which was also very 
significant (P < 0.05).  
The biceps group also had large increases in soreness levels from pre exercise to 
24 hours post exercise, where the healthy subjects had an 18.8 mm increase in muscle 
A B
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soreness (from 4.1 +/- 6.9 mm to 22.9 +/- 15.1 mm), and the diabetic group had a 23.3 
mm increase in muscle soreness (from 6.3 +/- 7.4 mm, to 29.5 +/- 11.6 mm). Both these 
increases were also significant (P < 0.05). It is also clear from figure 5 that the soreness 
levels for all the 4 groups were beginning to decrease but they didn’t reach near baseline 
levels as was the case for skin temperature measurements. 
 
 
 
Figure 5: A representative graph of the differences in perceived muscle soreness 
measured with the VAS in the healthy group who performed the P90x Abdominal 
exercise (diamonds), the diabetic group who performed the P90x Abdominal exercise 
(squares), the healthy group who performed the arm exercise (triangles), and the diabetic 
group who performed the arm exercise (X), over the 3 day time period. 
 
 
Myoglobin Concentrations 
 The results of the myoglobin readings for the 2 arm groups are shown in figure 6. 
As seen in figure 6, both groups had substantial increases in the myoglobin 
concentrations 48 hours post exercise. However, there was hardly any difference between 
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the 2 measurements (pre, and post) on day 1, for both the groups (P > 0.1). The healthy 
group had an increase of approximately 146 nanograms per milliliter (ng/mL) of blood on 
day 3, compared to day 1(from 31.03 +/- 8.25 to 177 +/- 222). This increase was highly 
significant (P < 0.05). The diabetic group who performed the same arm exercise had an 
even larger increase in myoglobin concentrations, when compared to the healthy 
individuals. This group had an increase of almost 337 ng/mL of blood at 48 hours, when 
compared to baseline (from 50.9 +/- 19.2 to 388.35 +/- 411.9). This increase in the 
myoglobin level was also very significant (P < 0.05). 
 A correlation analysis was done between the myoglobin measurements and the 
other 2 variables (skin temperature and VAS). It was found that there was a strong 
correlation between the peak skin temperature measurements (day 2), and the peak 
myoglobin readings (day 3). This correlation was highly significant (r = 0.41, P < 0.05). 
There was also a relevant correlation between the myoglobin readings on day 3, and the 
VAS measurements on day 3. This correlation was also very significant (r = 0.47, P < 
0.05).  
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Figure 6: A representative graph of the differences in Myoglobin levels between the 
healthy group who performed the arm exercise (diamonds), and the diabetic group who 
performed the arm exercise (squares) at 3 different time periods (Day 1 pre & post, and 
day 3). 
 
 
Discussion 
In the present investigation, subjects participated in an intense exercise program 
involving a single bout of exercise to identify the usability of thermal infra red imaging 
for detecting DOMS. From this investigation, it was found that IR imaging could be a 
valid technique for determining DOMS within the first day of exercising.  
Diabetes causes a chronic increase in whole body inflammation. 34 Due to this, 
and to the metabolic, and endothelial impairments associated with diabetes, exercise 
performance and training may become impaired in this population. 35,36 Even though in 
our investigation, both the diabetes groups did not exercise as hard as the other 2 groups, 
they had more muscle soreness than the healthier groups. However, exercise is still the 
best means of increasing glycemic control in diabetics because it enhances the body’s 
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insulin sensitivity. 1 Exercise has also been associated with a mean reduction in HbA1c of 
approximately 0.80%, especially muscle building exercises, as an increased overall 
muscle mass has been associated with better insulin sensitivity. 4,37 This obviously gives 
the diabetic individual a better chance of coping with the disease, and preventing its 
symptoms from getting worse. 2,38 
An interesting finding in this study was that the 2 groups who performed the 
abdominal exercise had higher skin temperatures, and increased soreness levels when 
compared to the groups who did the arm exercise. This could be due to the fact that the 
abdominal exercise was slightly longer in duration than the arm exercise, or because the 
abdominal muscles are larger in size than the biceps muscle. Another justification would 
be that the abdominal muscles are closer to the core, and are slightly warmer to begin 
with when compared to the peripheral arm muscles. 
Pennes 39 provided a very detailed model of heat flow from muscle to skin in 
limbs. This model predicts that heat in deeper tissues such as muscles can be dissipated 
into blood and into the skin through conductive heat exchange. When muscles exercise, 
heat is developed in the muscle due to frictional forces of the muscle fibers and from the 
increased metabolism. 40 Increased blood flows to the muscle would also contribute to the 
increased heat in the muscle after exercising. 
Skin is a shell tissue and its temperature is usually about 6 degrees less than that 
of the core. 41-43 The skin must be kept cooler than the core so that heat can move from 
the core to the skin and be removed by radiation, conduction and evaporation. 42,44-46 Heat 
moves from the muscle both into the blood perfusing muscle and is dissipated throughout 
the body and also flows to the cooler skin area. 39-41 This allows core temperature to be 
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maintained at a regulated level. 35,39,47 Muscle is also a shell tissue, where its temperature 
is usually 32 to 33 °C, which is slightly warmer than that of skin. However when blood 
flow is increased to the exercised muscle, it approaches the temperature of the core 
tissues which is approximately 37°C. 33,39 Blood flow in skeletal muscle is very dynamic. 
However, when tissue is damaged during exercise, blood flow can increase dramatically. 
Thus, warm blood entering muscle when tissue repair is being accomplished as part of 
the inflammatory response, can deliver a great deal of heat into the tissue. 6,48 The 
increased blood flow should go back to normal within an hour or two of the exercise 
termination, but when temperatures are still elevated at 24 hours post exercise, this shows 
that damage has happened to the exercised muscle and causes a hot spot under the skin. 
Thus, the elevated skin temperatures found 24 hours post exercise in all subjects 
is possibly the result of higher blood flows in muscle due to inflammation, and tissue 
damage repair. 6 Therefore, if muscle blood flow remained elevated post exercise, the 
warmer core blood would keep the muscle warm and hence the overlying skin would stay 
warm. This occurrence has been seen with thermal imaging for breast tumors in women, 
where tumors under the skin have this same effect and therefore form the basis for breast 
thermal imaging to detect tumors. 31,49 In fact, IR imaging has been used to detect and 
diagnose a number of other diseases, 30,32,33,50-52 as changes in the human body’s 
temperature has always been an indicator of some sort of dysfunction. 51 Increased 
circulation associated with delayed onset muscle soreness could also be seen as increased 
tissue temperature resulting from a muscular dysfunction. 
The elevated myoglobin concentrations on day 3 also verify this muscle soreness 
response after exercise. Myoglobin is a monomer protein, which has several functions 
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regarding oxygen storage and transport in the muscles. After strenuous exercise, 
myoglobin can be released in the bloodstream due to the breakdown of cell membranes in 
the exercised muscles. 53,54 Muscle damage Biomarkers, such as myoglobin, may increase 
30 minutes after exercising, and peak at 24 to 72 hours post exercise. 53 For that reason, 
we made a measurement of venous myoglobin at 48 hours post exercise, to identify the 
peak myoglobin response. Fortunately, as was seen in the correlation analyses, there was 
a strong relationship between the myoglobin concentrations on day 3, and the skin 
temperature measurements on the day before. This finding validates the usability of 
thermal imaging to detect DOMS in its initial stages. Even though skin temperatures and 
soreness levels were returning back to normal at 48 hours post exercise, the myoglobin 
concentrations were dramatically high. This exaggerated release of myoglobin from 
muscle could be due to the muscles response to the low grade inflammation and damage 
after the exercise. 53,55 
There were a couple of limitations in this study. First, the sample sizes weren’t 
equal between the groups that did the abdominal exercises, and the arm exercise groups. 
A main reason for this could be due to the fact that the arm exercise session, which was 
done prior to the abdominal exercise session, needed more commitment from the 
subjects, as it was extended to more than 3 days. Second, myoglobin was only measured 
for the arm exercise group. This was due to cost. Third, the exercise routines between the 
2 groups were different. However, this was necessary because the abdominal muscles are 
larger than the arm muscles, and an exercise that challenges the abdominal muscles, 
without causing back pain was needed for the purpose of this study. 
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Despite the limitations of this study, we have provided evidence to suggest that 
thermal imaging could be of great value in identifying which muscles have been 
exercised and are sore, hours or even days after the exercise is over. Thermal imaging 
would then be a painless, and non invasive way of detecting DOMS in its early stages, 
which could minimize further injuries from over-exercising in both healthy individuals, 
and in people who have diabetes. This could be more beneficial for the diabetic 
individuals, as they don’t always realize that they are sore, due to the neuropathies and 
impairments they have. 
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Short Abstract 
The purpose of this investigation was to assess whether using an infra-red thermal 
camera is a valid tool for detecting and quantifying the muscle soreness after exercising.  
 
Long Abstract 
Delayed onset muscle soreness (DOMS), also known as exercise induced muscle 
damage (EIMD), is commonly experienced in individuals who have been physically 
inactive for prolonged periods of time, and begin with an unexpected bout of exercise 1-4, 
but can also occur in athletes who exercise beyond their normal limits of training 5. The 
symptoms associated with this painful phenomenon can range from slight muscle 
tenderness, to severe debilitating pain 1,3,5. The intensity of these symptoms and the 
related discomfort increases within the first 24 hours following the termination of the 
exercise, and peaks between 24 to 72 hours post exercise 1,3. For this reason, DOMS is 
one of the most common recurrent forms of sports injury that can affect an individual’s 
performance, and become intimidating for many 1,4. 
For the last 3 decades, the DOMS phenomenon has gained a considerable amount 
of interest amongst researchers and specialists in exercise physiology, sports, and 
rehabilitation fields 6. There has been a variety of published studies investigating this 
painful occurrence in regards to its underlying mechanisms, treatment interventions, and 
preventive strategies 1-5,7-12. However, it is evident from the literature that DOMS is not 
an easy pathology to quantify, as there is a wide amount of variability between the 
measurement tools and methods used to quantify this condition 6. It is obvious that no 
agreement has been made on one best evaluation measure for DOMS, which makes it 
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difficult to verify whether a specific intervention really helps in decreasing the symptoms 
associated with this type of soreness or not. Thus, DOMS can be seen as somewhat 
ambiguous, because many studies depend on measuring soreness using a visual analog 
scale (VAS) 10,13-15, which is a subjective rather than an objective measure. Even though 
needle biopsies of the muscle, and blood levels of myofibre proteins might be considered 
a gold standard to some 6, large variations in some of these blood proteins have been 
documented 6,16, in addition to the high risks sometimes associated with invasive 
techniques.  
Therefore, in the current investigation, we tested a thermal infra-red (IR) imaging 
technique of the skin above the exercised muscle to detect the associated muscle 
soreness. Infra-red thermography has been used, and found to be successful in detecting 
different types of diseases and infections since the 1950’s 17. But surprisingly, near to 
nothing has been done on DOMS and changes in skin temperature. The main purpose of 
this investigation was to examine changes in DOMS using this safe and non-invasive 
technique. 
  
Protocol 
The Exercise 
The muscle of interest for this experiment was the elbow flexors (Biceps Brachii). 
Muscle strength was measured for each participant to be able to give each individual an 
appropriate resistance. This was determined by testing each participant for their 
resistance maximum (RM). For testing the RM, we used a strain gauge device interfaced 
with a computer through a BioPac (DA-100C) bioelectric amplifier module (BioPac 
Systems, Goleta, CA) to measure muscle strength. The module was connected to an MP-
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100 analog to digital converter sampling at a frequency of 1,000 hertz per second, and at 
a resolution of 24 bits (Fig. 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. A) The BioPac Modules used for measuring the muscle strength. B) The strain 
gauge device fixed to a 45° angled bench and hooked to the BioPac system. 
 
 
 
The strain gauge device was fixed to a bench at a 45° angle. The subjects were 
instructed to sit behind the device and rest their elbows on the padded area, so that the 
exertion force is through their wrists. This was the best way to insure that the subject will 
not recruit any muscle other than the biceps (Fig. 8). 
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Figure 8. A typical subject exerting force on the strain gauge device. 
 
 
Strength was determined on 3 occasions with each contraction being 3 seconds in 
duration with approximately 45 seconds separating the contractions.  The average of the 3 
measurements was the RM. After determining the RM for the biceps muscle of each 
participant, the intended session of exercise was carried out with 35% of their RM. All 
the subjects underwent the same exercise using appropriate weighted dumbbells to induce 
the muscle soreness (DOMS). This was carried out by doing 4 sets of 25 repetitions of 
biceps concentration curls while seated on a chair, and with the elbows supported on their 
thighs (Fig. 9) 
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Figure 9. A subject undergoing the exercise protocol for inducing muscle soreness. 
 
 
Each subject was given a 90 second resting period between each set. Subjects 
either did the full set of 25 repetitions, or were instructed to stop if they failed to steadily 
control the weight during the exercise. 
 
Infra-Red Camera Preparation & Setup 
The room where the infra-red imaging takes place was set at a constant 
temperature to minimize any external bias from differences in room temperature, which 
could lead to false thermal readings. For the purpose of this experiment we had a 
temperature controlled room which was maintained at approximately 23°C (+/- 0.5°C). 
The camera was set at a distance of 1 meter away, and at a perpendicular angle to the skin 
being measured. (Fig. 10a)* 
A  B 
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After the required distance was set up, the subjects were advised to stand still 
until the image has been taken. This shouldn’t take more than a couple of seconds, but it 
is very critical to minimize movement to insure the accuracy of the taken image. It is 
preferable that the room has darker colored paint, rather than lighter colors, to minimize 
any infra-red interference. Lighting is also critical when dealing with infra-red images, 
because light source that emit infra-red waves like fluorescent or tungsten lighting could 
give false high readings. The best lighting option would be a room equipped with 
uniform LED lights, as LED lights hardly produce any infra-red interference. (Fig. 10b) * 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 10. A) The Setup of the IR Camera 1 meter away from the subjects arm. B) The 
LED lights used in the lab where the images were taken. 
 
 
* A series of tests were done at our labs using the FLIR 660 IR Camera (Fig. 11), where 
we compared images of the skin at different angles (0 (perpendicular), 15, 30, 45, and 60 
degrees), and at different distances (1, 2, and 5 meters) from the skin, to accurately detect 
the temperature of the skin. All images were compared to calibrated thermocouples, and 
the best correlation between the images and the thermocouple readings was at a 
A  B 
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perpendicular angle and at a distance of 1 meter away from the skin (r = 0.93). The 
different angles and distances caused a pixilation loss, and decreased the overall 
correlation between the images and the thermocouple readings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. The IR thermal camera used for this investigation (FLIR 660) 
 
 
 
Image acquirement 
For the purpose of this experiment, the image of the exercised muscle was taken 
before the exercise, and at 24, and 48 hours post exercise. Body heat from sources other 
than the target could disrupt the thermal image and give false readings. For this reason, 
no one should be standing beside or behind the intended target. In this investigation, 
pictures of both the exercised and non-exercised arm were taken for comparison 
purposes. We exercised one of the arms, as was mentioned previously, and the other arm 
was used as a control. (Fig. 12 and 13). Image numbers from the IR camera were 
recorded immediately on a separate spreadsheet, as it could be difficult to identify which 
image belongs to whom. 
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Figure 12. A) a typical IR image of a subject’s exercised arm before the exercise. B) an 
IR image of the same subjects arm 24 hours after the exercise 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. A) a typical IR image of a subject’s un-exercised arm before the exercise. B) 
an IR image of the same subjects arm 24 hours after the exercise. 
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Image Processing & Analyses 
The acquired IR images were processed using the “ThermoVision® ExaminIR™” 
software Version: 1.10.2. After selecting the required image for analysis, four regions of 
interest were identified on the acquired image of the arm using statistical boxes on the 
software interface. (Fig.14) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. An illustration of the 4 regions of interest for analyzing the thermal image of 
the arm 
 
 
When the required regions across the arm have been located, the software shows 
the Means and Standard Deviations of the temperatures for each of the selected regions. 
Region 
4 
Region 
3 
Region 
2 
Region 
1 
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We can then either cross compare each region individually or obtain an average 
temperature of the whole arm. (Fig. 15) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Software interface for the “ ThermoVision® ExaminIR™ ” showing the 4 
boxes of interest on an IR image of an exercised arm. Also shown are the statistical 
interpretations for each box. 
 
 
Visual Analog Scale and Blood Analysis 
Visual analog scales (VAS) were used to assess subjective soreness of the arm. 
The scale had a 10 cm (100mm) long line marked “no pain” at one end, and “extremely 
sore” at the opposite end.  Each participant was directed to make a mark along the 10 cm 
line to indicate their response to soreness. The VAS’s were administered to the subjects 
before the exercise, 24 hours after the exercise, and at 48 hours. Peripheral blood was 
collected from the subjects to measure myoglobin concentration levels in the blood. 
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The blood was drawn from the subjects antecubital vein before the exercise, 30 minutes 
after the exercise was over, and at 48 hours. The blood was centrifuged at 4000 rpm for 
10 min to separate the serum from the cells. The samples were then stored at -80°C until 
the analyses of myoglobin was done. Myoglobin was measured using a TOSOH “AIA®-
360” Automated enzyme Immunoassay Analyzer (TOSOH Corp., Tokyo, Japan). The 
myoglobin Assay kits (Myo 025297, ST AIA-PACK Myoglobin) were used according to 
the manufactures instructions. 
 
Representative Results 
The results of IR thermal images taken during this investigation are clearly 
represented in Figure 16. Images taken at the 3 time periods (pre-exercise, 24 hours post-
exercise, and 48 hours post-exercise) for the exercised arms of the 41 subjects, showed a 
noticeable increase in temperature on day 2 (24 hours post-exercise) when compared to 
pre-exercise temperatures, and temperatures taken at 48 hours. As shown in Figure 1, the 
average skin temperature was 32.80 +/- 1.03 °C for day 1 (pre-exercise), and 33.96 +/- 
1.46 °C for day 2 (24 hours post-exercise), and 32.82 +/- 1.29 for day 3 (48 hours post-
exercise). This difference in skin temperature from day 1 to day 2 was significant 
(ANOVA p < 0.01).  
However, for the un-exercised arm, changes amongst the 3 time periods were not 
evident. Figure 16 shows that the average skin temperature was 33.08 +/- 0.83 °C for day 
1 (pre-exercise), and 32.79 +/- 1.42 °C for day 2 (24 hours post-exercise), and 33.17 +/- 
0.95 for day 3 (48 hours post-exercise). This difference in skin temperature over the 3 
days was not significant (ANOVA p = 0.38). 
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Figure 16. A representative graph of the differences in skin temperature in the 
exercised arms (Diamonds), and un-exercised arms (Squares) of the 41 subjects over 
the 3 day time period. 
 
 
The results of the pain readings from the VAS are shown in Figure 17. As seen in 
Figure 17, the reported pain had a dramatic increase on days 2 and 3. Pain levels of the 
exercised muscle increased from 3.6 +/- 6.1 on day 1, to 36.3 +/- 22.8 on day 2, and 37.5 
+/- 25.3 on day 3. This increase from day 1 was significant (ANOVA p < 0.01). 
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Figure 17. A representative graph of the differences in perceived muscle soreness 
measured with the VAS over the 3 day time period for all the 41 subjects. 
 
 
The results of the myoglobin concentration levels are shown in Figure 18. As seen 
in this figure, there was hardly any change between the 2 myoglobin concentrations on 
day 1 (pre, & 30 minutes post exercise). But on day 3, the increase in myoglobin was 
very large. This increase on day 3 was approximately 147 nanograms per milliliter 
(ng/mL) of blood when compared to the first 2 concentrations on day 1. Myoglobin 
concentrations were 30.12 +/- 7.66 ng/mL at baseline, 31.66 +/- 11.89 ng/mL 30 minutes 
post exercise, and 178.96 +/- 249.51 ng/mL on day 3. This increase on day 3 was highly 
significant (ANOVA p < 0.01). 
 
3.61
36.27 37.54
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
Pre‐Exercise 24 Hours Post‐Exercise 48 Hours Post‐Exercise
VAS Scores from Pre‐Exercise to 48 Hours 
Post‐Exercise
49 
 
Figure 18. A representative graph of the differences in myoglobin concentrations for 
all the 41 subjects over the 3 time periods. 
 
A correlation analysis was done between the skin temperatures obtained from the IR 
images, and the VAS soreness levels. It was found that there was a considerable 
correlation between the VAS readings on day 2, and the skin temperature measurement 
on day 2. This correlation was significant (r = 0.312, p < 0.05). However, there was no 
evident correlation between the VAS readings and the skin temperatures on day 3. This 
correlation was insignificant (r = 0.047, p = 0.77). 
 
Discussion 
The primary purpose of this investigation was to assess the usefulness of thermal 
IR imaging in detecting and measuring muscle soreness after strenuous exercise, and our 
results suggest that IR imaging could be a valid technique for detecting DOMS, 
30.12 31.66
178.96
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
160.0
180.0
200.0
220.0
Pre‐Exercise 30 Minutes Post‐Exercise 48 Hours Post‐Exercise
Myoglobin Concentrations from Pre‐
Exercise to 48 Hours Post‐Exercise
50 
especially within the first 24 hours of exercising. This is not surprising, as Pennes 18 
provided a very detailed model of heat flow from muscle to skin in limbs. This model 
predicts that heat in deeper tissues such as muscles can be dissipated into blood and into 
the skin through conductive heat exchange. When muscles exercise, obviously, 
tremendous heat is developed in the muscle due to frictional forces of the muscle fibers 
and because of the increased metabolism. Increased blood flows to the muscle would also 
contribute to the increased heat in the muscle after exercising. Because muscle is a shell 
tissue, the temperature is usually 32 to 33 °C, however when blood flow is increased to 
the exercised muscle it approaches the temperature of the core tissues which is 37°C 18,19. 
This increased blood flow should go back to normal within a couple of hours after the 
exercise termination. But when temperatures are still elevated at 24 hours post exercise, 
this shows that damage has happened to the exercised muscle. This damage in the muscle 
causes additional heat transfer from the muscle to the overlying skin, which causes a 
detectable hot spot under the skin. 
IR imaging has been used to detect and diagnose many diseases 17,19-24. Changes 
in the human body’s temperatures have always been indicators of dysfunction, where 
increased heat is mainly associated with some sort of inflammation or infection 17. Thus, 
the elevated skin temperatures found 24 hours post exercise in all subjects is possibly the 
result of higher blood flows in muscle due to inflammation, and tissue damage repair 2. 
Also, no noticeable increases in the skin temperature of the un-exercised arm occurred 
during the 3 days of the study. Therefore, if muscle blood flow remained elevated in the 
exercised arm, the warmer blood would keep the muscle warm and hence the overlying 
skin would stay warm. As a result, breast tumors in women and skin cancer can be easily 
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detected by IR imaging because of the increased blood flows to the affected lesion site 
20,21.  
The elevated soreness levels (VAS) on day 2 and 3, and the increased myoglobin 
concentrations on day 3 are both indicators of DOMS. This shows that the subjects did 
get sore after the exercise session. As was seen in the results, there was a relationship 
between the increased skin temperatures on day 2, and the increased soreness levels on 
that same day. Myoglobin concentrations were still elevated on day 3, while skin 
temperatures were returning back to normal. This delayed release of myoglobin into the 
blood, could be due to the muscles slower response to inflammation and damage that 
occurs in the muscle fibers after exercise 25,26.  
However, 3 to 5 days later, there can still be minor tissue repair and 
reconstruction, even though the blood flow maybe close to normal. That’s why on the 3rd 
day we did not see a correlation between skin temperature and soreness levels, because 
the damage was already done. Therefore, we believe that this is predictive of soreness, 
because it shows that if you get sustained 24 hours increase in tissue blood flow, then you 
know that you’ve got damage to the tissue. This damage was verified by the VAS 
readings, and the myoglobin concentrations in the blood. Thus, the higher the skin 
temperature readings 24 hours post exercise, the sorer the subject would be later on. 
Hence, IR thermal imaging would be of great value in detecting DOMS in its 
early stages. It would also be an interesting, and painless way of looking at muscles that 
have been exercised and are sore, hours after the exercise is over. In a sports setting, this 
early detection of DOMS could help in lowering the incidence of injuries from over-
exercising sore muscles on days following the initial exercise. 
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Equipment Used 
Several devices were used throughout this study, and Table 2 below shows 
specific model information for these devices. 
 
Table 2: Table of specific equipment. 
Name of the Device Company Catalogue 
number 
Comments (optional) 
Infra-Red Thermal 
Camera 
FLIR FLIR SC660   
Thermal Infra-Red 
Analysis Software 
ThermoVision
® ExaminIR™
Software 
Version 1.10.2
 
Bioelectric Amplifier 
Module 
BioPac DA100C The DA100C provides variable gain 
settings, and adjustable voltage references.
Analog to Digital 
Converter Module 
BioPac MP100  
Automated enzyme 
Immunoassay Analyzer 
TOSOH AIA -360 This device was used to analyze the blood 
samples, and obtain the myoglobin 
readings. 
  
53 
References 
1. Cheung, K., Hume, P. A. & Maxwell, L. Delayed Onset Muscle Soreness: Treatment 
strategies and Performance Factors. Sports Med 33, 145-164 (2003). 
2. MacIntyre, D. L., Reid, W. D. & McKenzie, D. C. Delayed Muscle Soreness: The 
Inflammatory Response to Muscle Injury and its Clinical Implications. Sports Med 
20, 24-40 (1995). 
3. Armstrong, R. B. Mechanisms of exercise-induced delayed onset muscular soreness: 
a brief review. Medicine and Science in Sports and Exercise 16, 529-538 (1984). 
4. Howatson, G. & Someren, K. A. V. The Prevention and Treatment of Exercise-
Induced Muscle Damage. Sports Med 38, 483-503 (2008). 
5. Petrofsky, J. et al. Comparison of Different Heat Modalities for Treating Delayed-
Onset Muscle Soreness in People with Diabetes. Diabetes Technology & 
Therapeutics 13, 645-655, doi:10.1089/dia.2011.0002 (2011). 
6. Warren, G. L., Lowe, D. A. & Armstrong, R. B. Measurement Tools Used in the 
Study of Eccentric Contraction-Induced Injury. Sports Med 27, 43-59 (1999). 
7. Hilbert, J. E., Sforzo, G. A. & Swensen, T. The Effects of Massage on Delayed Onset 
Muscle Soreness. Br J Sports Med 37, 72-75 (2003). 
8. Symons, T. B., Clasey, J. L., Gater, D. R. & Yates, J. W. Effects of Deap Heat as a 
Preventative Mechanism on Delayed Onset Muscle Soreness. Journal of Strength and 
Conditioning Research 18, 155-161 (2004). 
9. Vaile, J. M., Gill, N. D. & Blazevich, A. J. The Effect of Contrast Water Therapy on 
Symptoms of Delayed Onset Muscle Soreness. Journal of Strength and Conditioning 
Research 21, 697-702 (2007). 
10. Stone, M. B., Merrick, M. A., Ingersoll, C. D. & Edwards, J. E. Preliminary 
Comparison of Bromelain and Ibuprofen for Delayed Onset Muscle Soreness 
Management. Clinical Journal of Sports Medicine 12, 373-378 (2002). 
11. Barlas, P. et al. Managing Delayed-Onset Muscle Soreness: Lack of Effect of 
Selected Oral Systemic Analgesics. Arch Phys Med Rehabil 81, 966-972 (2000). 
12. Jackman, S. R., Witard, O. C., Jeukendrup, A. E. & Tipton, K. D. Branched-Chain 
Amino Acid Ingestion Can Ameliorate Soreness from Eccentric Exercise. Medicine 
& Science in Sports & Exercise 42, 962-970, doi:10.1249/MSS.0b013e3181c1b798 
(2010). 
13. Frey Law, L. A. et al. Massage Reduces Pain Perception and Hyperalgesia in 
Experimental Muscle Pain: A Randomized, Controlled Trial. The Journal of Pain 9, 
714-721, doi:10.1016/j.jpain.2008.03.009 (2008). 
54 
14. Vaile, J., Halson, S., Gill, N. & Dawson, B. Effect of hydrotherapy on the signs and 
symptoms of delayed onset muscle soreness. European Journal of Applied Physiology 
102, 447-455, doi:10.1007/s00421-007-0605-6 (2007). 
15. Vinck, E., Cagnie, B., Coorevits, P., Vanderstraeten, G. & Cambier, D. Pain 
reduction by infrared light-emitting diode irradiation: a pilot study on experimentally 
induced delayed-onset muscle soreness in humans. Lasers in Medical Science 21, 11-
18, doi:10.1007/s10103-005-0366-6 (2006). 
16. Clarkson, P. M. & Ebbeling, C. Investigation of Serum Creatine Kinase Variability 
after Muscle-Damaging Exercise. Clin Sci 75, 257-261 (1988). 
17. Jiang, L. J. et al. A perspective on medical infrared imaging. Journal of Medical 
Engineering & Technology 29, 257-267, doi:10.1080/03091900512331333158 
(2005). 
18. Pennes, H. H. Analysis of Tissue and Arterial Blood Temperatures in the Resting 
Human Forearm. J Appl Physiol 1, 93-122 (1948). 
19. Ivanitsky, G. R., Khizhnyak, E. P., Deev, A. A. & Khizhnyak, L. N. Thermal imaging 
in medicine: A comparative study of infrared systems operating in wavelength ranges 
of 3–5 and 8–12 μm as applied to diagnosis. Doklady Biochemistry and Biophysics 
407, 59-63, doi:10.1134/s1607672906020049 (2006). 
20. Herman, C. & Cetingul, M. P. Quantitative Visualization and Detection of Skin 
Cancer Using Dynamic Thermal Imaging. JoVE 51, doi:10.3791/2679 (2011). 
21. Wang, J. et al. Evaluation of the diagnostic performance of infrared imaging of the 
breast: a preliminary study. BioMedical Engineering OnLine 9, 3, doi:10.1186/1475-
925x-9-3 (2010). 
22. Murray, A. K. et al. Noninvasive imaging techniques in the assessment of 
scleroderma spectrum disorders. Arthritis & Rheumatism 61, 1103-1111, 
doi:10.1002/art.24645 (2009). 
23. Zaproudina, N., Ming, Z. & Hanninen, O. O. P. Plantar Infrared Thermography 
Measurements and Low Back Pain Intensity. Journal of Manipulative and 
Physiological Therapeutics 29, 219-223 (2006). 
24. Kim, Y.-C., Bahk, J.-H., Lee, S.-C. & Lee, Y.-W. Infrared Thermographic Imaging in 
the Assessment of Successful Block on Lumbar Sympathetic Ganglion. Yonsei 
Medical Journal 44, 119-124 (2003). 
25. Brancaccio, P., Lippi, G. & Maffulli, N. Biochemical markers of muscular damage. 
Clinical Chemistry and Laboratory Medicine 48, 757-767, 
doi:10.1515/cclm.2010.179 (2010). 
26. Neubauer, O., König, D. & Wagner, K.-H. Recovery after an Ironman triathlon: 
sustained inflammatory responses and muscular stress. European Journal of Applied 
Physiology 104, 417-426, doi:10.1007/s00421-008-0787-6 (2008). 
55 
 
 
CHAPTER FOUR 
THE EFFECTS OF BRANCHED-CHAIN AMINO ACID SUPPLEMENTATION ON 
DELAYED ONSET MUSCLE SORENESS IN PEOPLE WITH DIABETES 
 
 
By: 
Hani H. Al-Nakhli, MPT, Ph.D(C) 
Jerrold S. Petrofsky, PhD, J.D. 
Lee S. Berk, DrPH. 
Darshita Dalal, MPT. 
Inayat Kaur, MPT. 
Vinit Dubey, MPT. 
Swetha Regula, MPT. 
 
 
 
 
 
 
 
  
56 
Abstract 
For individuals with diabetes, exercise is important for maintaining proper 
glycemic control. However, exercise induces muscle soreness, making it problematic for 
these individuals to maintain exercise regimes. In younger non-diabetic individuals, 
studies have shown that nutritional supplementation including branched chain amino 
acids (BCAA), enhance muscle recovery. The purpose of this blinded study was to assess 
the effects of BCAA supplementation on delayed onset muscle soreness (DOMS) in 
diabetics compared to healthy controls. Forty-four subjects; 28 healthy, and 16 with 
diabetes, were randomly assigned to either the BCAA or placebo group. Measurements 
including muscle strength, electromyography response of the biceps muscle during 
maximum effort, perceived soreness, serum myoglobin concentration, elbow range of 
motion, and skin temperatures were collected before the biceps exercise session and for 
the five following days. The results showed that while serum myoglobin concentrations 
increased at 48 hours for both the healthy and diabetic subjects, it was significantly 
higher (P = 0.013) in the diabetic subjects who took the placebo supplement (pre-exercise 
= 54.5 +/- 8 ng/mL, 48 hours = 767.1 +/- 189 ng/mL) when compared to those who took 
the BCAA supplement (pre-exercise = 51.4 +/- 7 ng/mL, 48 hours = 158.1 +/- 62 ng/mL). 
Pain was 79.6% higher in the diabetic group who took the placebo when compared to the 
BCAA group (P = 0.017). In conclusion, BCAA supplementation reduced muscle 
damage and muscle soreness in diabetic subjects, whereas they had minimal effects on 
the healthy control subjects. 
 
Keywords: BCAA, DOMS, Diabetes, Exercise  
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Introduction 
The diabetes epidemic is on the rise in both developing and developed countries 
[1,2]. According to the World Health Organization (WHO) and recent estimates, the 
disease now affects approximately 345 million people worldwide and is expected to 
affect around 440 million by 2030, representing almost 8% of the global adult population 
[3,4]. Lifestyle characteristics such as obesity, a sedentary lifestyle, and lack of physical 
activity are regarded as the most important risk factors, both independently associated 
with diabetes and diabetes related co-morbidities [5,6].  
Exercise is considered a major cornerstone of diabetes management. Studies have 
shown that exercise is recommended as part of the treatment and prevention of type 2 
diabetes mellitus (T2DM) [7,5,8]. Even though aerobic exercise has beneficial effects for 
managing and treating T2DM, it has been found that resistance-type exercise is also 
effective in controlling blood glucose, and in reducing Hemoglobin A1c (HbA1c) levels 
[7,9-11]. It is best for individuals with diabetes to participate in a combination of both 
aerobic and resistance exercise to properly manage their blood glucose levels. The effects 
of combined exercise have shown more pronounced outcomes on glycemic control, 
muscle strength, and insulin sensitivity [7,9,12]. A study done by Church and colleagues 
[9], showed that a combination exercise group decreased their diabetes medication 
dependency, when compared to a control group who had increased their use of diabetes 
medications. It would be imperative then, to include resistance training as a primary step 
in the exercise schedule of a diabetic patient. This is particularly important for obese 
individuals, since aerobic exercise may be challenging for them. 
Resistance training would be more beneficial for individuals with diabetes to 
begin with, as it contributes to the recruitment of previously inactive muscle fibers, which 
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would enhance the quality of the muscle, and lead to gains in muscle mass [13,7,14]. This 
would result in increased whole body insulin sensitivity, and improved glucose control 
[13,7,5]. 
Delayed onset muscle soreness (DOMS) however, is a phenomenon that occurs in 
skeletal muscle as a result of novel or unaccustomed exercise [15-17]. The severity of the 
damage and the extent of discomfort is exacerbated over time, and occurs minutes to days 
after the acute exercise bout [15,16]. The intensity of the symptoms and discomfort 
associated with DOMS usually peaks between 24 to 72 hours post exercise, and can last 
for up to 10 days, especially when the exercise bout encompasses an eccentric component 
[17-19]. Activities that are comprised of repeated eccentric contractions have been shown 
to result in damage to the ultrastructure of skeletal muscle[20,21]. This damage manifests 
itself as a temporary decrease in muscle function, restricted range of motion in the 
associated joint, increased muscle soreness, an increased swelling of the involved muscle 
group, and an increase in intramuscular proteins in blood such as creatine kinase, and 
myoglobin[22,23,20]. Consequently, DOMS is considered one of the most common 
recurrent forms of injury, which can lead to further injuries if a premature return to 
exercise is attempted [16]. For this reason, pain associated with DOMS can reduce an 
individual’s willingness to exercise. 
Not much is known about DOMS in people with diabetes. However, Studies have 
shown that older individuals have reduced proteolytic activity and an elevated production 
in free radicals [24,25]. This elevation in free radicals prolongs healing time after 
excessive exercise [24]. With higher levels of free radicals, metabolic impairments, and 
59 
endothelial dysfunction, in people with diabetes [26,27], DOMS has been found to be 
more severe in this population [26,28]. 
As a result of these observations, methods to alleviate the severity of DOMS, and 
to minimize the damage resulting from resistance exercises have been investigated. 
Treatment strategies including massage (depending on the time and type of massage) [29-
31], water baths [32,33], and the administration of non-steroidal anti-inflammatory drugs 
(NSAID) [34-36] have shown varying results. Other treatment strategies such as 
cryotherapy, stretching, homeopathy, and ultrasound have shown minimal to no effect on 
the improvement of muscle soreness [15,37,38,16,39,40]. However, in regards to acute 
nutritional interventions, there is evidence that suggests ingesting protein supplements 
which are high in branched chain amino acids (BCAA) can attenuate muscle damage, 
reduce muscle soreness, and promote enhanced recovery of muscle function [41,22,23]. 
Resistance exercise causes decreases of some of the essential amino acids, 
including BCAA, during the recovery period after the exercise [42,43]. Resistance 
exercise then, alters the turnover of muscle protein by increasing the amino acid transport 
within the muscle [43]. This enhances both the rates of skeletal muscle protein synthesis, 
and protein breakdown during the recovery period following even a single bout of 
exercise [44,43]. Skeletal muscle however, remains in an overall catabolic state unless 
muscle protein synthesis surpasses muscle protein degradation, and for this to take place, 
adequate nutritional intervention is necessary during this recovery period [44,45]. Thus, 
when essential amino acids (EAA) are ingested in conjunction with an acute bout of 
resistance training, the hypertrophic response is enhanced resulting in a net increase in 
muscle protein synthesis, thereby improving performance [22,46]. 
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Among these EAA, exceptional results have been observed with BCAA, and 
specifically leucine [46,47]. Studies have indicated that BCAA are mainly used by active 
skeletal muscles during submaximal exercise, whereas most other amino acids are 
metabolized in the liver [42,48]. 
Recent findings suggest that BCAA can be safely consumed in large doses with 
no adverse effects in healthy adults, when compared to other amino acids in protein 
[49,50]. Furthermore, the ingestion of acute doses of BCAA supplements containing all 3 
BCAA (leucine, isoleucine, and valine) appears to be well tolerated by adults, because 
human cells have a tightly controlled enzymatic system for BCAA degradation [50,47]. 
Numerous studies have investigated the effects of BCAA supplementation on 
skeletal muscle soreness. Some found that BCAA may be useful for muscle recovery 
following acute sessions of exercise, both in trained and untrained individuals 
[22,51,45,52,23]. In contrast, other studies showed no effects of BCAA ingestion on 
DOMS [53,46]. However, no study to date has assessed the effectiveness of BCAA 
supplements on DOMS in a diabetic population. Thus, the purpose of this study was to 
examine the effectiveness of BCAA supplementation on reducing DOMS. We 
hypothesized that BCAA supplementation would be beneficial in alleviating DOMS by 
reducing muscle damage, and maintaining the functional performance of the exercised 
muscle. 
 
Subjects and Methods 
Forty four subjects participated in this study. There were 2 groups, one group of 
healthy individuals which consisted of 28 subjects, and another group of 16 diabetic 
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subjects. The participants in these 2 groups were randomly assigned into either the 
experimental group, who ingested the BCAA supplement, or the placebo group. All the 
subjects were physically inactive for at least 3 weeks prior to participating in the study. 
Subjects were excluded if they were pregnant, had hepatic diseases, were diagnosed with 
Rhabdomyolysis, or an impaired circulatory disease (such as Raynaud’s), had any recent 
upper limb injuries, had severe neuropathies in their upper limbs, were hypertensive 
(blood pressure over 145/95 mmHg), or were on high doses of alpha or beta 
agonist/antagonists, Cox 2 inhibitors, calcium channel blockers, or pregabalins. Also, 
subjects were advised not to take any pain reducers, NSAID, or dietary supplements 
during the course of the study. The average age, height, weight, and demographics of the 
subjects are shown in Table 3. Subjects were informed of all experimental procedures and 
protocols and signed a statement of informed consent as approved by the Institutional 
Review Board (IRB) of Loma Linda University. 
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Table 3: Means (+/- SEM) of the general characteristics of the Subjects 
Subject 
Type 
Suppleme
nt 
N Age 
(Years)
Height 
(Cm) 
Weight 
(Kg) 
BMI HbA1c 
(%) 
Diabetes 
Duration 
(Years) 
Healthy 
Individuals 
BCAA 14 28.2 (+/-  
2.0) 
168.3 
(+/- 2.1) 
72.9 (+/- 
4.7) 
25.2 
(+/- 
1.3) 
  
Placebo 14 28.07 
(+/- 2.1) 
168.0 
(+/- 2.3) 
72.7 (+/- 
5.0) 
25.5 
(+/- 
1.4) 
  
Diabetic 
Individuals 
BCAA 8 60.6 (+/- 
5.7) 
166.7 
(+/- 5.5) 
98.7 (+/- 
11.8) 
34.8 
(+/- 
3.0) 
7.5 (+/- 
0.8) 
7.7 (+/- 
2.3) 
Placebo 8 61.9 (+/- 
3.3) 
168.5 
(+/- 4.9) 
118.9 
(+/- 
15.5) 
41.3 
(+/- 
4.2) 
6.7 (+/- 
0.4) 
5.5 (+/- 
1.9) 
 
 
Study Design 
This study was a double blinded randomized controlled trial. The subjects and the 
examiners were blinded to the supplement taken, and the subjects were randomly 
allocated into either the experiment group, or the placebo group. All measurements were 
taken at 6 time periods: a baseline measurement taken pre-exercise (baseline), and post-
exercise measurements at 30 minutes (day1), 24 hours (day2), 48 hours (day3), 72 hours 
(day4), and 96 hours (day5). The serum myoglobin measurements were taken at 5 
occasions, where all measurements were taken at the same time periods except for day2 
(at 24 hours). 
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The Supplement Protocol 
The subjects in the experimental group took 3 doses of the BCAA supplement. 
The first dose was taken 30 minutes before the workout, the 2nd dose was taken 
immediately after completing the workout, and the 3rd dose was taken on the 2nd day (24 
hours post exercise). The amount of BCAA supplement administered to the subjects in 
the experimental group on day 1 was a total dose of 1 gram of BCAA per kilogram of 
lean body mass (a bioelectric impedance analyzer was used to measure lean body mass as 
described below). This dose was divided in half and administered at the two specified 
occasions for the 1st day. The 3rd dose (on day 2) was equivalent to 0.8 grams per kilo of 
lean body weight, and was administered before any measurements were taken on that 
day. The ratio of isoleucine, leucine, and valine used in this study was 1:2.5:1 
respectively. The subjects in the placebo group were administered 3 doses of a placebo 
supplement at the exact same times as above. The placebo supplement consisted of 
cellulose powder, which has no effects on skeletal muscle. Both the BCAA and the 
placebo supplement were mixed in a low calorie fruit flavored drink. The tastes of both 
the BCAA and placebo drinks were identical. Two teaspoons of artificial sweetener was 
added to both supplements to mask the slight bitterness of the supplements. 
 
The Resistance Maximum (RM) and Muscle Strength (MS) Testing 
A strength measuring device with 4 strain gauges placed on opposite sides of a 
steel bar (arranged as a Wheatstone bridge) was used to measure each individuals 
resistance maximum (RM) and muscle strength (MS). When the bar bends, the strain 
gauges get deformed and an electrical output is provided. This device was interfaced with 
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a computer through a BioPac (DAC-100) bioelectric amplifier module (BioPac Systems, 
Goleta, CA). This module was connected to a BioPac MP-150 analog to digital converter 
sampling at a frequency of 1,000 Hz per second, and at a resolution of 24 bits. The output 
signal was amplified 5,000 times. Data analysis and storage was done on Acknowledge 
9.1 software from BioPac (BioPac Systems, Goleta, CA). This method has also been 
described elsewhere [28]. 
The device was fixed to a bench at a 45° angle, so that only the biceps would be 
recruited. Subjects sat behind this bench with their intended arm aligned to the device. 
The strap attached to the strain gauge device was placed on the subject’s wrist, and an 
examiner instructed each subject when to exert their maximal force and when to relax 
(Fig. 19). Strength was determined on 3 occasions with each contraction being 3 seconds 
in duration and approximately 1 minute apart. The average of these 3 measurements was 
considered their maximum strength. The baseline (pre-exercise) MS measurement was 
also considered the subjects’ RM. After determining the RM for the biceps muscle of 
each subject, the intended session of exercise was done with 35% of their RM. 
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Figure 19: A typical subject setup for the repetition maximum (RM) and muscle strength 
(MS) measurements while the examiner is giving verbal cues. Also seen here is the strain 
gauge device with the wrist strap, securely attached to the 45° angled bench. 
 
 
Electromyography (EMG) Assessment 
Surface EMG was recorded from the exercised biceps muscle and sampled by 2 
bipolar vinyl adhesive EMG electrodes with an active surface area of 0.5 cm2. One 
electrode was placed on the mid-belly of the biceps brachii muscle and the other 
electrode was placed immediately distal to it. The position of both electrodes was 
immediately marked with permanent ink to ensure consistent placement on subsequent 
testing days. The ground electrode was attached to the forearm, and the position was also 
marked with permanent ink. The electrodes were connected to a BioPac (EMG-100B) 
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electromyogram amplifier module (BioPac Systems, Goleta, CA), which was interfaced 
with a computer. This module was connected to a BioPac MP-150 analog to digital 
converter. The raw EMG signal was collected at a frequency of 1,000 Hz per second, at a 
resolution of 24 bits, and amplified 5,000 times. Before recording, signals were visually 
inspected to ensure background noise and artifacts were minimized. The EMG 
measurements were standardized in that all measures were taken during the MS 
measurements. The EMG readings were recorded at the same time the subjects were 
instructed to contract their muscles for the MS measurement. 
 
Soreness/Pain Measurements 
The short form McGill pain questionnaire (SF-MPQ) has been identified as a 
reliable measure of pain [54,55], and was used to assess subjective soreness of the arm 
muscles on all days of the experiment.  The benefit of this scale over the typical visual 
analog scale is that this scale is divided into 4 simple sections (a sensory pain rating 
index, an affective pain rating index, a present pain intensity rating, and an evaluative 
overall intensity of total pain), which gives a better overview of the type and intensity of 
the perceived pain. The subjects placed a check mark on the appropriate columns of each 
type of pain, to indicate their response to soreness. 
 
Relaxed Elbow Range of Motion (RROM) 
Measurements of elbow resting angles were assessed using a universal 
goniometer with subjects positioned in a standardized manner. During all the 
measurements, the subjects were sitting in an armless chair so that they sat in an erect 
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position with the trunk supported and the feet on the floor. The arm, shoulder, and trunk 
were maintained in a neutral position throughout testing. The lines of the humerus and 
radius were used as standardization points. The lateral epicondyle of the humerus was 
considered the goniometric axis of movement, and was marked with a semi-permanent 
pen on all subjects. The reliability of this measurement technique has been demonstrated 
[56]. The range of motion measured for the purpose of this study was the elbow angle at 
rest, taken as the angle of the elbow while the arm hung loosely by the subjects side. 
Each measurement was repeated 3 times, and the average of all 3 measurements was the 
final measurement used. All measurements were obtained by the same experimenter, 
using the same goniometer, in order to minimize any measurement error. 
 
Blood Sampling & Measurement of Myoglobin Concentrations 
 Approximately 4 mL peripheral blood was collected from an antecubital vein. 
Peripheral venous blood was drawn on all days of the experiment, except day 2. The 
blood was allowed to clot at room temperature for 10 minutes, before it was spun down 
in a refrigerated centrifuge at 4000 rpm for 10 min to separate the serum from the cells. 
The serum samples were then stored at -80°C until the analyses was done. 
Serum myoglobin was determined using a TOSOH “AIA®-360” automated 
enzyme immunoassay analyzer (TOSOH Corp., Tokyo, Japan). The myoglobin Assay 
kits (Myo 025297, ST AIA-PACK Myoglobin) were used according to the manufactures 
instructions. Controls were run before and after each assay session, to verify that the 
measurements were accurate and within the manufacturers specified quality control 
ranges. The normal reference range for myoglobin using this method was 31.4 - 971 
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ng/mL. The intra-assay and inter-assay coefficient of variations were 2.76 %, and 4.45 % 
respectively. 
 
Skin Temperature 
 Skin temperature was measured using a Flir TC660 Thermal Camera (Stockholm, 
Sweden). The thermal image taken of the exercised arm was taken from approximately 1 
meter away, and perpendicular to the skin. From a series of tests done at our labs using 
the FLIR 660 IR Camera, this distance and angle were found to have the best correlation 
(r = 0.93) with thermocouple readings. The images were taken in a temperature 
controlled room which was maintained at approximately 23°C (+/- 0.5°C). The 
temperatures from the acquired image were measured at 4 locations on the skin above the 
biceps muscle using the “ThermoVision® ExaminIR™” software Version: 1.10.2. These 
4 readings were analyzed individually and then averaged to give a full perspective of the 
temperature above the exercised muscle. 
 
Lean Body Weight Determination 
Lean body weight was determined by electrical impedance with an RJL Systems 
Quantum 2 Bioelectric Impedance Analyzer (Minneapolis, MN).  The unit measured 
resistance and reactance with 1.0 ohms of resolution. Four electrodes were placed on the 
body, two source electrodes on the hand and foot and two recording electrodes on the 
hand and foot.  The system placed a current of approximately 0.1 milliamps at 100,000 
cycles per second frequency, through the source electrodes.  The recording electrodes 
recorded the signal transmitted through the body, and use this to calculate body fat 
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content via the software provided by the manufacturer (RJL Systems).  The Quantum 2 
with the multiplexed cable, allows multi-zone and segmental measurements to be taken 
quickly and easily in 26 segments to calculate body water and body fat. 
 
Food Dietary Analysis 
 Diet was assessed at baseline using the Brief Block Food Frequency 
Questionnaire (FFQ) (Block Dietary Data Systems, Berkeley, CA, 
www.nutritionquest.com) . This questionnaire has been shown to be a valid tool for 
assessing different types of nutritional components [57,58]. 
 
Procedure 
First, demographical data was collected including: height, weight, age, body fat, 
body mass index (BMI), blood pressure, and medical history. Also, baseline data of all 
the previously indicated measurements were collected (MS, EMG, SF-MPQ, and 
RROM), including blood samples for the myoglobin measurement, and the 
administration of the brief FFQ. The initial dose of the supplement, whether BCAA or 
placebo, was also administered at this time. The targeted muscles for this experiment 
were the elbow flexors. The resistance exercise was performed using a dumbbell, and 
DOMS was only induced in the subjects’ dominant arm. To provoke DOMS in these 
muscles, all subjects carried out 4 sets of 25 repetitions of biceps concentration curls 
while seated on a chair, and the elbows supported on their thighs. Subjects were advised 
to lower the weight and lift it at a steady rate (approximately 3 seconds going down, and 
3 seconds coming back up), to ensure that the eccentric component of the muscle 
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contraction was properly done. There was a 90 second resting period between sets, and 
subjects either did the full set of 25 repetitions, or were instructed to stop the set if they 
failed to steadily control the descent of the weight and return their arm back to full 
flexion. As indicated previously, the resistance used was 35% of each subject’s RM. 
All the primary measurements were repeated after the exercise at 30 minutes, 24, 
48, 72, and 96 hours except for the myoglobin measure which wasn’t carried out at 24 
hours. Also, the 2nd and 3rd dose of the supplements were taken immediately after the 
exercise and at 24 hours. 
 
Data Analysis 
Means, and standard errors (SEM) were calculated. Measurements of all variables 
(MS, EMG, RROM, SF-MPQ, Myoglobin, and Skin Temperatures) were compared over 
time between the experimental and placebo groups of each of the 2 main groups (healthy 
and diabetic) using a mixed factorial (2 × 6) analysis of variance (ANOVA). When a 
significant difference over time was found, a paired t-test was performed to determine 
any significant differences from baseline. Demographic data and the protein intake (from 
the FFQ analysis) were compared using independent-t tests. Statistical analysis was 
performed using PASW Statistics Version 18.0.0 (SPSS, Inc., 2009, Chicago, IL, 
www.spss.com), and the level of significance was set at α < 0.05. 
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Results 
Demographics and Protein Intake 
There were no significant differences in demographic data between the two 
treatment groups of the healthy subjects group (P > 0.05). Also, no significant difference 
between the baseline protein intakes was observed. The same results were also seen for 
the diabetic subjects group, where no significant differences were found between the two 
treatment groups in regards to demographical data, and protein intake (P > 0.05). 
 
Muscle Strength (MS) 
There was no significant difference in MS between the two treatment groups in 
the healthy group (P > 0.1). However, there was a difference in MS over time, with a 
significant decrease in MS at day1 (P < 0.01), compared to baseline. 
In the diabetic group, there was no significant difference in MS between the two 
treatment groups (P > 0.1). However, there was a significant decrease in MS at day1 (P < 
0.05), compared to baseline. Figure 20 shows the MS response for all 4 groups. 
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Figure 20: Graph of the muscle strength measures (Means +/- SEM) in the healthy group 
who ingested the BCAA supplement (diamonds), the healthy group who ingested the 
Placebo supplement (squares), the diabetic group who ingested the BCAA supplement 
(triangles), and the diabetic group who ingested the Placebo supplement (X), over the 6 
time periods. 
 
 
 
Electromyography (EMG) 
There was no significant difference in EMG between the two treatment groups in 
the healthy group (P > 0.1). There was also no significant difference over time (P > 0.05). 
In the diabetic group however, there was a significant difference in EMG between 
the two treatment groups (P < 0.05), where the placebo group had a significantly lower 
EMG amplitude during maximum effort when compared to the BCAA group. There was 
also a difference in EMG over time, with a significant decrease in EMG at day3, day4, 
and day5 (P < 0.05), compared to baseline. Figure 21 illustrates the EMG response during 
maximum effort for all 4 groups. 
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Figure 21: Graph of the electromyography (EMG) amplitude during maximum effort 
(Means +/- SEM) in the healthy group who ingested the BCAA supplement (diamonds), 
the healthy group who ingested the Placebo supplement (squares), the diabetic group who 
ingested the BCAA supplement (triangles), and the diabetic group who ingested the 
Placebo supplement (X), over the 6 time periods. 
 
Soreness/Pain Response (SF-MPQ) 
There was no significant difference in the pain scores from the SF-MPQ among 
the two treatment groups in the healthy group (P > 0.1). Pain scores differed overtime 
however, where there was a significant increase in pain at day1, day2, day3, and day4 (P 
< 0.05), compared to baseline. 
In the diabetic group, there was a significant difference between the two treatment 
groups in regards to the level of perceived pain (P < 0.05), where the placebo group had 
higher pain than the BCAA group. A difference in pain over time was also found, where 
there was a significant increase in pain at day2, day3, and day4 (P < 0.05), compared to 
baseline in the placebo group. In the BCAA group however, the only significant time 
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difference from baseline was at day 3 (P < 0.05). Figure 22 shows the pain scores from 
the SF-MPQ for all 4 groups. 
 
 
Figure 22: Graph of the soreness responses using the SF-MPQ (Means +/- SEM) in the 
healthy group who ingested the BCAA supplement (diamonds), the healthy group who 
ingested the Placebo supplement (squares), the diabetic group who ingested the BCAA 
supplement (triangles), and the diabetic group who ingested the Placebo supplement (X), 
over the 6 time periods. 
 
Relaxed Range of Motion (RROM) 
There was no significant difference in RROM between the two treatment groups 
in the healthy group (P > 0.1). However, there was a difference in RROM over time, with 
a significant decrease in RROM for all time points (day1, day2, day3, day4, day5) 
compared to baseline (P < 0.05). 
Also in the diabetic group, where there was no significant difference in RROM 
between the two treatment groups (P > 0.1). However, there was a significant decrease in 
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RROM at day1, day2, day3, and day4 (P < 0.05), compared to baseline. Figure 23 shows 
the RROM measurements in all 4 groups. 
 
 
Figure 23: Graph of the relaxed range of motion (RROM) measurements (Means +/- 
SEM) in the healthy group who ingested the BCAA supplement (diamonds), the healthy 
group who ingested the Placebo supplement (squares), the diabetic group who ingested 
the BCAA supplement (triangles), and the diabetic group who ingested the Placebo 
supplement (X), over the 6 time periods. 
 
Myoglobin Concentrations 
There was no significant difference in myoglobin concentrations between the two 
treatment groups in the healthy group (P > 0.1). However, there was a difference in 
myoglobin concentrations over time, with a significant increase in myoglobin 
concentrations at day3, day4, and day5 (P < 0.05) compared to baseline. 
In the diabetic group, there was a significant difference in myoglobin 
concentrations between the two treatment groups (P < 0.05), where the placebo group had 
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higher blood myoglobin concentrations than the BCAA group. A difference over time 
was also found, with a significant increase in myoglobin concentrations at day3, day4, 
and day5 (P < 0.05), compared to baseline in the placebo group. In the BCAA group 
however, the only significant time difference from baseline was at day 4 (P < 0.05). 
Figure 24 shows the blood myoglobin concentrations for all 4 groups. 
 
 
 
Figure 24: Graph of the blood myoglobin concentrations (Means +/- SEM) in the healthy 
group who ingested the BCAA supplement (diamonds), the healthy group who ingested 
the Placebo supplement (squares), the diabetic group who ingested the BCAA 
supplement (triangles), and the diabetic group who ingested the Placebo supplement (X), 
over the 5 time periods. 
 
 
Skin Temperatures 
 There was no significant difference in skin temperatures between the two 
treatment groups in the healthy group (P > 0.05). However, there was a difference over 
time, with a significant increase in skin temperatures at day1 (P < 0.05), compared to 
baseline for both groups. Skin temperatures in the placebo group were still significantly 
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elevated at day 2 (P < 0.05) compared to baseline, whereas in the BCAA group, skin 
temperatures at day 2 were not significantly different from baseline (P > 0.05). 
 Also in the diabetic group, where there was no significant difference in skin 
temperatures between the treatment groups (P > 0.05). There was however, a time 
difference, where there was a significant increase in skin temperatures at day1 (P < 0.05), 
compared to baseline for both groups. Also, similar to the diabetic group, skin 
temperatures for the placebo group were still significantly elevated at day 2 (P < 0.05) 
compared to baseline, whereas for the BCAA group there was no significant difference 
between day 2 and baseline measures (P > 0.05). Figure 25 shows the skin temperature 
measurements for all 4 groups. 
 
 
Figure 25: Graph of skin temperatures (Means +/- SEM) in the healthy group who 
ingested the BCAA supplement (diamonds), the healthy group who ingested the Placebo 
supplement (squares), the diabetic group who ingested the BCAA supplement (triangles), 
and the diabetic group who ingested the Placebo supplement (X), over the 6 time periods. 
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Discussion 
 Exercise is still considered one of the best means of increasing glycemic control 
in people with diabetes, particularly resistance exercise [7]. It has been shown that an 
overall increase in muscle mass is associated with better insulin sensitivity [13,9]. 
Resistance exercise however, especially the eccentric phase, has been attributable to 
micro-traumas and damage of protein structures within skeletal muscles [38,20,59]. This 
damage alters the protein turnover process within the muscle, which causes a decrease in 
performance and in the body’s BCAA content (and some other essential amino acids) 
during the recovery period after exercise [44,43,42]. 
There has been a heightened interest lately in nutritional supplementation, in 
treating DOMS and its associated symptoms. In these studies, BCAA has been found to 
have promising effects in facilitating the restoration of muscle function, and attenuating 
muscle damage following exercise [22,45,60,51,52,23]. However, because people with 
diabetes have endothelial dysfunction, soreness levels are worse after exercise and 
recovery periods longer [26,28]. 
No study up to date has investigated BCAA effects on a diabetic population, 
which was the focus of this study. In this investigation, subjects participated in a 
moderate intensity resistance exercise to induce DOMS, and identify the effectiveness of 
BCAA supplementation in enhancing the recovery of DOMS, and its perceived 
symptoms. This study was also unique in the fact that we used a BCAA dosage 
dependent on lean body weight, rather than just the individual’s weight. The reason for 
incorporating this method is that diabetic individuals, on average, have higher fat 
distributions when compared to non-diabetic individuals. Also, because BCAA is mainly 
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metabolized in skeletal muscle, we thought that the incorporation of the individual’s 
whole body weight in the dosage calculation might not be necessary. From this 
investigation, we found that BCAA supplementation could be a useful method for 
treating DOMS and facilitating muscle recovery in a diabetic population.  
 BCAA when consumed before or after an acute exercise session has been found 
to further stimulate muscle protein synthesis, and reduce muscle protein breakdown, 
resulting in an enhanced muscle adaptation to the related damage [46,45,47]. These 
positive results were seen in the diabetic group, where some of the muscle damage 
markers were decreased when compared to the placebo group.  
In regards to the EMG response, the diabetic BCAA group showed a better 
maintenance of their muscle activity output, while the diabetic placebo group had a larger 
decrease. This could be attributed to the fact that an increased dose of leucine has been 
found to help maintain the muscles force output during isometric contractions [22]. 
Perceived soreness, and myoglobin concentrations in the diabetic BCAA group were 
much lower than in the diabetic placebo group. This response has been observed in a 
number of studies that have incorporated the use of BCAA, or leucine supplementation 
on the markers of muscle damage and DOMS [52,60]. Although skin temperatures were 
not significantly different between the two diabetic groups, a notable finding was that 
skin temperatures were closer to baseline in the BCAA group at 24 hours, while 
temperatures were still elevated in the placebo group at that same time period. This 
indicates that there were higher blood flows in the exercised muscle of the placebo group, 
due to increased inflammation and tissue damage [59]. 
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An interesting finding in our study was that the BCAA supplement had enhanced 
the recovery in the diabetic group, but had almost no effects on the healthy group, even 
though the dosage duration was short. A critical explanation for this occurrence could be 
ascribed to the fact that diabetic individuals have a high prevalence of gastrointestinal 
complications including dyspepsia, and abdominal pain [61,62]. Diabetes mellitus is 
known to provoke many complications such as retinopathy and nephropathy; 
gastrointestinal dysfunction is just one of these many complications [61,63]. Neuropathy 
and hyperglycemia have been found to cause abnormal gastrointestinal motility and 
disturbed digestion, which together have shown to cause impaired intestinal absorption 
[64-66]. This may result in the mal-absorption of essential amino acids from the proteins 
in the diet of a diabetic individual. Thus, an amino acid supplement would be much easier 
for the diabetic individual to absorb through an impaired gastrointestinal system. 
On the other hand, we found no significant differences between the healthy 
BCAA group, and the healthy placebo group. A main reason for this finding could be 
related to the fact that the supplementation duration wasn’t long enough. Studies have 
concluded that the duration of BCAA supplementation could have a large impact on its 
effects on DOMS [67,53]. For example, a study done by Sharp and colleagues [45] found 
that BCAA supplementation had significant effects on lowering DOMS, but their 
supplementation period was over the length of 4 weeks (3 weeks before the exercise, and 
1 week after). These positive effects were seen even though the exercise routine they 
incorporated was intense, as it included muscles of the whole body (circuit training) 
rather than just the arm, or leg muscles. Also, another study done by Skillen and 
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colleagues [68], administered an amino acid supplement over a period of 2 weeks and 
found that it had beneficial effects on reducing muscle damage markers.  
One of the limitations of this study is that we only assessed the subject’s dietary 
intake at baseline, and failed to assess their intake over the course of the study. This 
obviously limits our ability to detect changes in intake, especially in regards to protein 
content. Another limitation would be the fact that we didn’t incorporate a strict dietary 
program for the subjects during the time of the study. However, even though this would 
increase the studies internal validity, it might decrease its external validity. Suggestions 
for further studies would be to incorporate different vitamins into the BCAA supplement. 
Vitamin E would be a good example, as it is considered an antioxidant, which has been 
found to be effective in attenuating exercise induced muscle damage [15,69]. 
 Despite the limitations of this study, we have provided suggestive evidence that 
BCAA supplementation in a diabetic population can be beneficial in enhancing muscle 
performance, and improving recovery from DOMS. BCAA supplementation would be a 
simple method for stabilizing the muscle’s protein content after an acute bout of 
resistance exercise in people with diabetes. This could assist in minimizing further 
injuries from over-exercising in this population. However, further investigations are 
required to clarify and elucidate these findings. 
 
Acknowledgments 
No external financial support was used for this study. We would like to thank the 
Saudi Arabian Ministry of Higher Education (MOHE), and the Saudi Arabian Cultural 
Mission (SACM) for their cooperation and support. We would also like to thank the 
82 
Physical Therapy Department at the School of Allied Health Professions (SAHP) at 
Loma Linda University (LLU). We would also like to acknowledge everyone who 
assisted us in the clinical lab including: Paula Cavalcanti, Bhargav Dave, and Harold 
Moniz for their time and effort.  
  
83 
References 
1. Al-Hussein FA (2008) Diabetes control in a primary care setting: a retrospective 
study of 651 patients. Ann Saudi Med 28 (4):267-271 
2. Sarah Wild GR, Anders Green, Richard Sicree, Hilary King (2004) Global Prevalence 
of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 
27:1047-1053 
3. J.E. Shaw RAS, P.Z. Zimmet (2010) Global estimates of the prevalence of diabetes 
for 2010 and 2030. Diabetes Research and Clinical Practice 87:4-14 
4. Collins Boakye-Agyemang FI, Devan Mohee, Souleymane Koné, Henry Bastienne, 
José Dacosta Caetano (2009) The Challenge of Diabetes by 2030.  
5. Praet SFE, Loon LJC (2009) Exercise therapy in Type 2 diabetes. Acta Diabetologica 
46 (4):263-278. doi:10.1007/s00592-009-0129-0 
6. Hills AP, Shultz SP, Soares MJ, Byrne NM, Hunter GR, King NA, Misra A (2009) 
Resistance training for obese, type 2 diabetic adults: a review of the evidence. 
Obesity Reviews 11 (10):740-749. doi:10.1111/j.1467-789X.2009.00692.x 
7. Zanuso S, Jimenez A, Pugliese G, Corigliano G, Balducci S (2009) Exercise for the 
management of type 2 diabetes: a review of the evidence. Acta Diabetologica 47 
(1):15-22. doi:10.1007/s00592-009-0126-3 
8. A. Honkola TF, J. Eriksson (1997) Resistance training improves the metabolic profile 
in individuals with type 2 diabetes. Acta Diabetologica 34:245-248 
9. Church TS, Blair SN, Cocreham S, Johannsen N, Johnson W, Kramer K, Mikus CR, 
Myers V, Nauta M, Rodarte RQ, Sparks L, Thompson A, Earnest CP (2010) Effects 
of Aerobic and Resistance Training on Hemoglobin A1c Levels in Patients With 
Type 2 Diabetes. JAMA: The Journal of the American Medical Association 304 
(20):2253-2262 
10. Castaneda C (2003) Diabetes control with physical activity and exercise. Nutrition in 
clinical care 6 (2):89-96 
11. Nathan K. LeBrasseur KW, Zoltan Arany (2010) Metabolic benefits of resistance 
training and fast glycolytic skeletal muscle. Am J Physiol Endocrinol Metab 300:E3–
E10 
12. Umpierre D, Ribeiro PAB, Kramer CK, Leita˜o CB, Zucatti ATN, Azevedo MJ, 
Gross JL, Ribeiro JP, Schaan BD (2011) Physical Activity Advice Only or Structured 
Exercise Training and Association With HbA1c Levels in Type 2 Diabetes: A 
Systematic Review and Meta-analysis. JAMA: The Journal of the American Medical 
Association 305 (17):1790-1799 
 
84 
13. Srikanthan P, Karlamangla AS (2011) Relative Muscle Mass Is Inversely Associated 
with Insulin Resistance and Prediabetes. Findings from The Third National Health 
and Nutrition Examination Survey. Journal of Clinical Endocrinology & Metabolism. 
doi:10.1210/jc.2011-0435 
14. Meex RCR, Schrauwen-Hinderling VB, Moonen-Kornips E, Schaart G, Mensink M, 
Phielix E, van de Weijer T, Sels JP, Schrauwen P, Hesselink MKC (2009) 
Restoration of Muscle Mitochondrial Function and Metabolic Flexibility in Type 2 
Diabetes by Exercise Training Is Paralleled by Increased Myocellular Fat Storage and 
Improved Insulin Sensitivity. Diabetes 59 (3):572-579. doi:10.2337/db09-1322 
15. Howatson G, Someren KAV (2008) The Prevention and Treatment of Exercise-
Induced Muscle Damage. Sports Med 38 (6):483-503 
16. Cheung K, Hume PA, Maxwell L (2003) Delayed Onset Muscle Soreness: Treatment 
strategies and Performance Factors. Sports Med 33 (2):145-164 
17. Armstrong RB (1984) Mechanisms of exercise-induced delayed onset muscular 
soreness: a brief review. Medicine and Science in Sports and Exercise 16 (6):529-538 
18. Evans WJ (1992) Exercise, Nutrition and Aging. Journal of Nutrition 122:796-801 
19. Diamond Nguyen LEB, Jared W. Coburn, Daniel A. Judelson, Alea D. Eurich, Andy 
V. Khamoui, Brandon P. Uribe (2009) Effect of delayed-onset muscle soreness on 
elbow flexion strength and rate of velocity development. Journal of Strength and 
Conditioning Research 23 (4):1282–1286 
20. Kazunori Nosaka MN, Paul Sacco (2002) Muscle damage and soreness after 
endurance exercise of the elbow flexors. Medicine & Science in Sports & Exercise 34 
(6):920-927 
21. Akihiro Sakamoto TM, Hisashi Naito, Peter J. Sinclair (2010) Acute Effects of High 
Intensity Dumbbell Exercise After Isokinetic Eccentric Damage: Interaction between 
altered pain perception and fatigue on static and dynamic muscle performance. 
Journal of Strength and Conditioning Research 24 (8):2042-2049 
22. Kirby TJ, Triplett NT, Haines TL, Skinner JW, Fairbrother KR, McBride JM (2011) 
Effect of leucine supplementation on indices of muscle damage following drop jumps 
and resistance exercise. Amino Acids. doi:10.1007/s00726-011-0928-9 
23. Kraemer WJ, Ratamess NA, Volek JS, Häkkinen K, Rubin MR, French DN, Gómez 
AL, McGuigan MR, Scheett TP, Newton RU, Spiering BA, Izquierdo M, Dioguardi 
FS (2006) The effects of amino acid supplementation on hormonal responses to 
resistance training overreaching. Metabolism 55 (3):282-291. 
doi:10.1016/j.metabol.2005.08.023 
 
 
85 
24. Evans WJ (1992) Exercise, nutrition and aging. J Nutr 122 (3 Suppl):796-801 
25. Fielding RA, Meredith CN, O'Reilly KP, Frontera WR, Cannon JG, Evans WJ (1991) 
Enhanced protein breakdown after eccentric exercise in young and older men. J Appl 
Physiol 71 (2):674-679 
26. Petrofsky J, Batt J, Bollinger JN, Jensen MC, Maru EH, Al-Nakhli HH (2011) 
Comparison of Different Heat Modalities for Treating Delayed-Onset Muscle 
Soreness in People with Diabetes. Diabetes Technology & Therapeutics 13 (6):645-
655. doi:10.1089/dia.2011.0002 
27. Kanter MM (1994) Free radicals, exercise, and antioxidant supplementation. Int J 
Sport Nutr 4 (3):205-220 
28. Al-Nakhli HH, Petrofsky JS, Laymon MS, Arai D, Holland K, Berk LS (2011) The 
Use of Thermal Infrared Imaging to Assess the Efficacy of a Therapeutic Exercise 
Program in Individuals with Diabetes. Diabetes Technology & 
Therapeutics:111019130632009. doi:10.1089/dia.2011.0187 
29. Frey Law LA, Evans S, Knudtson J, Nus S, Scholl K, Sluka KA (2008) Massage 
Reduces Pain Perception and Hyperalgesia in Experimental Muscle Pain: A 
Randomized, Controlled Trial. The Journal of Pain 9 (8):714-721. 
doi:10.1016/j.jpain.2008.03.009 
30. Hilbert JE, Sforzo GA, Swensen T (2003) The Effects of Massage on Delayed Onset 
Muscle Soreness. Br J Sports Med 37:72-75 
31. Zainal Zainuddin MN, Paul Sacco, Kazunori Nosaka (2005) Effects of Massage on 
Delayed-Onset Muscle Soreness, Swelling, and Recovery of Muscle Function. 
Journal of Athletic Training 40 (3):174-180 
32. Vaile JM, Gill ND, Blazevich AJ (2007) The Effect of Contrast Water Therapy on 
Symptoms of Delayed Onset Muscle Soreness. Journal of Strength and Conditioning 
Research 21 (3):697-702 
33. Vaile J, Halson S, Gill N, Dawson B (2007) Effect of hydrotherapy on the signs and 
symptoms of delayed onset muscle soreness. European Journal of Applied Physiology 
102 (4):447-455. doi:10.1007/s00421-007-0605-6 
34. Barlas P, Craig JA, Robinson J, Walsh DM, Baxter GD, Allen JM (2000) Managing 
Delayed-Onset Muscle Soreness: Lack of Effect of Selected Oral Systemic 
Analgesics. Arch Phys Med Rehabil 81:966-972 
35. Pizza FX CD, Stockard A, Baylies H, Beighle A (1999) Anti-inflammatory doses of 
ibuprofen: effect on neutrophils and exercise-induced muscle injury. International 
Journal of Sports Medicine 20 (2):98-102 
 
86 
36. Michael O'Grady ACH, Kenneth Schneider, Edward Bossen, Karl Steinberg, James 
M Douglas Jr, William J Murray, W. David Watkins (2000) Diclofenac sodium 
(Voltaren) reduced exercise-induced injury in human skeletal muscle. Medicine & 
Science in Sports & Exercise 32 (7):1191–1196 
37. Howatson G, Gaze D, van Someren KA (2005) The efficacy of ice massage in the 
treatment of exercise-induced muscle damage. Scandinavian Journal of Medicine and 
Science in Sports 15 (6):416-422. doi:10.1111/j.1600-0838.2005.00437.x 
38. Symons TB, Clasey JL, Gater DR, Yates JW (2004) Effects of Deap Heat as a 
Preventative Mechanism on Delayed Onset Muscle Soreness. Journal of Strength and 
Conditioning Research 18 (1):155-161 
39. Dawn T. Gulick IFK, Michael Sitler, Albert Paolone, John D. Kelly (1996) Various 
Treatment Techniques on Signs and Symptoms of Delayed Onset Muscle Soreness. 
Journal of Athletic Training 31 (2):145-152 
40. William Kirk Isabell ED, William Myrer, Shauna Anderson (1992) The Effects of Ice 
Massage, Ice Massage with Exercise, and Exercise on the Prevention and Treatment 
of Delayed Onset Muscle Soreness. Joumal of Athletic Training 27 (3):208-217 
41. Betts JA, Toone RJ, Stokes KA, Thompson D (2009) Systemic indices of skeletal 
muscle damage and recovery of muscle function after exercise: effect of combined 
carbohydrate-protein ingestion. Applied Physiology, Nutrition, and Metabolism 34 
(4):773-784. doi:10.1139/h09-070 
42. Mero A (1999) Leucine supplementation and Intensive Training. Sports Med 27 
(6):347-358 
43. Eva Blomstrand BE-G (2009) Changes in amino acid concentration in plasma and 
type I and type II fibres during resistance exercise and recovery in human subjects. 
Amino Acids 37:629-636 
44. W. Apro´ EB (2010) Influence of supplementation with branched-chain amino acids 
in combination with resistance exercise on p70S6 kinase phosphorylation in resting 
and exercising human skeletal muscle. Acta Physiologica 200:237-248 
45. Carwyn P.M. Sharp DRP (2010) Amino Acid Supplements and Recovery from High-
Intensity Training. Journal of Strength and Conditioning Research 24 (4):1125-1130 
46. Matt S. Stock JCY, Lawrence A. Golding, Laura J. Kruskall, Richard D. Tandy, 
Janice M. Conway-Klaassen, Travis W. Beck (2010) The Effects of Adding Leucine 
to Pre and Postexercise Carbohydrate Beverages on Acute Muscle Recovery from 
Resistance Training. Journal of Strength and Conditioning Research 24 (8):2211-
2219 
47. Yoshiharu Shimomura TM, Naoya Nakai, Masaru Nagasaki, Robert A. Harris (2004) 
Exercise Promotes BCAA Catabolism: Effects of BCAA Supplementation on 
Skeletal Muscle during Exercise. Journal of Nutrition 134:1583S-1587S 
87 
48. Yoshiharu Shimomura TH, Makoto Shiraki, Taro Murakami, Juichi Sato, Hisamine 
Kobayashi, Kazunori Mawatari, Mariko Obayashi, Robert A. Harris (2006) 
Branched-Chain Amino Acid Catabolism in Exercise and Liver Disease. Journal of 
Nutrition 136:250S-253S 
49. Matthews DE (2005) Observations of Branched-Chain Amino Acid Administration in 
Humans. Journal of Nutrition 135:1580S–1584S 
50. Gleeson M (2005) Interrelationship between Physical Activity and Branched-Chain 
Amino Acids. Journal of Nutrition 135:1591S–1595S 
51. Jackman SR, Witard OC, Jeukendrup AE, Tipton KD (2010) Branched-Chain Amino 
Acid Ingestion Can Ameliorate Soreness from Eccentric Exercise. Medicine & 
Science in Sports & Exercise 42 (5):962-970. doi:10.1249/MSS.0b013e3181c1b798 
52. Matsumoto K, Mizuno M, Mizuno T, Dilling-Hansen B, Lahoz A, Bertelsen V, 
Münster H, Jordening H, Hamada K, Doi T (2007) Branched-chain Amino Acids and 
Arginine Supplementation Attenuates Skeletal Muscle Proteolysis Induced by 
Moderate Exercise in Young Individuals. International Journal of Sports Medicine 28 
(6):531-538. doi:10.1055/s-2007-964940 
53. Knechtle B, Knechtle P, Mrazek C, Senn O, Rosemann T, Imoberdorf R, Ballmer P 
(2011) No effect of short-term amino acid supplementation on variables related to 
skeletal muscle damage in 100 km ultra-runners - a randomized controlled trial. 
Journal of the International Society of Sports Nutrition 8 (1):6. doi:10.1186/1550-
2783-8-6 
54. Strand L, Ljunggren A, Bogen B, Ask T, Johnsen T (2008) The Short-Form McGill 
Pain Questionnaire as an outcome measure: Test–retest reliability and responsiveness 
to change. European Journal of Pain 12 (7):917-925. 
doi:10.1016/j.ejpain.2007.12.013 
55. Kate V. Grafton NEF, Christine C. Wright, (2005) Test-Retest Reliability of the 
Short-Form McGill Pain Questionnaire. Clinical Journal of Pain 21 (1):73-82 
56. April D Armstrong JCM, Shrikant Chinchalkar, Rob S. Stevens, Graham J.W. King 
(1998) Reliability of range-of-motion measurement in the elbow and forearm. J 
Shoulder Elbow Surg 7:573-580 
57. Julie A. Mares-Perlman BEKK, Ronald Klein, Linda L Ritter, Marian R. Fisher, Jo L 
Freudenheim (1993) A Diet History Questionnaire Ranks Nutrient Intakes in Middle-
Aged and Older Men and Women Similarly to Multiple Food Records. Journal of 
Nutrition 123:489-501 
58. Block G TF, Hartman AM, Larkin FA, Guire KE (1992) Comparison of two dietary 
questionnaires validated against multiple dietary records collected during a 1-year 
period. J Am Diet Assoc 92 (6):686-693 
88 
59. MacIntyre DL, Reid WD, McKenzie DC (1995) Delayed Muscle Soreness: The 
Inflammatory Response to Muscle Injury and its Clinical Implications. Sports Med 20 
(1):24-40 
60. Yoshiharu Shimomura YY, Gustavo Bajotto, Juichi Sato, Taro Murakami, Noriko 
Shimomura, Hisamine Kobayashi, Kazunori Mawatari (2006) Nutraceutical Effects 
of Branched-Chain Amino Acids on Skeletal Muscle. Journal of Nutrition 136:529S-
532S 
61. Oh J-H, Choi M-G, Kang M-I, Lee K-M, Kim JI, Kim B-W, Lee D-S, Kim S-S, Choi 
H, Han S-W, Choi K-Y, Son H-Y, Chung I-S (2009) The Prevalence of 
Gastrointestinal Symptoms in Patients with Non-Insulin Dependent Diabetes 
Mellitus. The Korean Journal of Internal Medicine 24 (4):309. 
doi:10.3904/kjim.2009.24.4.309 
62. Amer Shakil RJC, Shobha S. Rao (2008) Gastrointestinal Complications of Diabetes. 
American Family Physician 77 (12):1697-1702 
63. Khaled M. Elsayes COM, Lina Sierra, Jonathan R. Dillman, Joel F. Platt (2009) 
Gastrointestinal Manifestations of Diabetes Mellitus: Spectrum of Imaging Findings. 
J Comput Assist Tomogr 33:86-89 
64. Russell Yang RA, Lawrence Chan (1984) Gastrointestinal Tract Complications of 
Diabetes Mellitus: Pathophysiology and Management. Arch Intern Med 144:1251-
1256 
65. Camilleri M (1996) Gastrointestinal problems in diabetes. Endocrinol Metab Clin 
North Am 25 (2):361-378 
66. Lawrence A. Szarka MC (2010) Stomach Dysfunction in Diabetes Mellitus: 
Emerging Technology and Pharmacology. Journal of Diabetes Science and 
Technology 4 (1):180-189 
67. Nosaka K SP, Mawatari K (2006) Effects of amino acid supplementation on muscle 
soreness and damage. Int J Sport Nutr Exerc Metab 16 (6):620-635 
68. Skillen RA TM, Applegate EA, Heiden EA, Fascetti AJ, Casazza GA (2008) Effects 
of an amino acid carbohydrate drink on exercise performance after consecutive-day 
exercise bouts. Int J Sport Nutr Exerc Metab 18 (5):473-492 
69. Bloomer RJ (2007) The Role of Nutritional Supplements in the Prevention and 
Treatment of Resistance Exercise-Induced Skeletal Muscle Injury. Sports Med 37 
(6):519-532 
  
89 
 
 
CHAPTER FIVE 
DISCUSSION 
 
In the present reseaerch, we examined the intensity of DOMS in people who have 
diabetes, in 2 different body regions (Chapter 2). As an outcome of the first study, we 
then investigated a new technique to objectively quantify muscle soreness (Chapter 3). 
Finally, using this new technique and other biomarkers, we examined whether soreness 
could be reduced by ingesting a single nutritional supplement, which in this case was 
BCAA (Chapter 4). 
Diabetes causes a chronic increase in whole body inflammation. 54 Because of 
this, and of the metabolic and endothelial impairments associated with diabetes, exercise 
performance and training may become impaired in this population. 56,57 It has been shown 
that exercise which results in an overall increase in muscle mass is associated with better 
insulin sensitivity, and a mean reduction in hemoglobin A1c of approximately 0.80%. 
12,16 This obviously gives the individual with diabetes a better chance of coping with the 
disease and preventing its symptoms from getting worse. 7,58 For these reasons, resistance 
exercise is considered one of the best means of increasing glycemic control in people 
with diabetes. 10 Resistance exercise however, especially the eccentric phase, has been 
attributable to micro-traumas and damage of protein structures within skeletal muscles. 
23,34,59 This damage alters the protein turnover process within the muscle, which causes a 
decrease in BCAA and some other essential amino acids during the recovery period after 
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exercise. 44-46 A decrease in performance occurs during this recovery period, but BCAA 
supplementation has been found to facilitate the restoration of muscle function. 25,47,60  
While much is known about DOMS in young people, little is known about DOMS 
in people with diabetes. However, there may be some comparisons that can be made from 
studies of DOMS and ageing. 61 These studies have shown that there is reduced 
proteolytic activity and an elevated production in free radicals in older individuals. 61,62 
This elevation prolongs healing time after excessive exercise. 61 With metabolic 
impairments, endothelial dysfunction, and higher levels of free radicals in people with 
diabetes53,63 DOMS could be more severe and recovery periods longer in this population. 
To understand DOMS however, we need a marker of DOMS, and in this 
dissertation we used common markers such as; myoglobin and soreness scales. But the 
most interesting finding was being able to use a non-invasive marker, which was 
objectively valid and correct. 
In this investigation, it was found that infrared imaging could be a valid technique 
for determining DOMS within the first days of exercising. A purpose of this investigation 
was to assess the usefulness of thermal imaging in detecting and measuring muscle 
soreness after strenuous exercise. Our results suggest that thermal imaging could be a 
valid technique for detecting DOMS, especially within the first 24 hours of exercising. 
As well as being able to measure skin temperature, thermal cameras are fairly 
inexpensive. 
Pennes 64 provided a very detailed model of heat flow from muscle to skin in 
limbs. This model predicts that heat in deeper tissues such as muscles can be dissipated 
into blood and into the skin through conductive heat exchange. When muscles exercise, 
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heat is developed in the muscle because of frictional forces of the muscle fibers and from 
the increased metabolism.65 Increased blood flows to the muscle would also contribute to 
the increased heat in the muscle after exercising. 
Skin is a shell tissue, and its temperature is usually about 6°C less than that of the 
core. 66-68 The skin must be kept cooler than the core so that heat can move from the core 
to the skin and be removed by radiation, conduction, and evaporation. 68-71 Muscle is also 
a shell tissue, where its temperature is usually 32−33°C, which is slightly warmer than 
that of skin. However, when blood flow is increased to the exercised muscle it 
approaches the temperature of the core tissues, which is approximately 37°C. 39,64 Blood 
flow in skeletal muscle is very dynamic, and when tissue is damaged during exercise, 
blood flow can increase dramatically. Thus, warm blood entering muscle when tissue 
repair is being accomplished as part of the inflammatory response can deliver a great deal 
of heat into the tissue. 34,72 The increased blood flow should go back to normal within an 
hour or two of the exercise termination, but when temperatures are still elevated at 24 
hours post-exercise, this shows that damage has happened to the exercised muscle and 
causes a hot spot under the skin. 
Thus, the elevated skin temperatures found 24 hours post-exercise in all subjects 
is possibly the result of higher blood flows in muscle due to inflammation and tissue 
damage repair. 34 Therefore, if muscle blood flow remained elevated post-exercise, the 
warmer core blood would keep the muscle warm, and hence the overlying skin would 
stay warm. This occurrence has been used to detect and diagnose several other diseases 
using thermal imaging. 35-39,73-75 This is true because changes in the human body’s 
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temperatures have always been indicators of dysfunction, where increased heat is mainly 
associated with inflammation or infection. 35  
The elevated soreness levels, and the increased myoglobin concentrations are both 
indicators of DOMS. This verifies that the subjects did get sore after the exercise session. 
Myoglobin is a monomer protein, which has several functions regarding oxygen storage 
and transport in the muscles. After strenuous exercise, myoglobin can be released in the 
bloodstream because of the breakdown of cell membranes in the exercised muscles. 76,77 
Concentrations of muscle myoglobin markers in the blood, may increase 30 min after 
exercising and peak at 24-72 hours post-exercise. 76 
Certainly being able to quantify DOMS is important, but preventing it is as 
important, especially in a diabetic population. Even though we would have liked to 
investigate several nutritional supplements and vitamins, but because of financial and 
time limitations, we chose to investigate only one supplement which was BCAA 
There has been a heightened interest lately in nutritional supplementation, in 
treating DOMS and its associated symptoms. In these studies, BCAA has shown 
promising effects in attenuating muscle damage following exercise. 25,26,47,51,52,60 
However, because people with diabetes have endothelial dysfunction, soreness levels 
may be worse after exercise and recovery periods longer. 53 In addition, no study to date 
has investigated the effects of BCAA in people with diabetes, which was one of the 
focuses of this experiment.  
 BCAA, when consumed before or after an acute exercise, has been found to 
further stimulate muscle protein synthesis and reduce muscle protein breakdown, 
resulting in an enhanced muscle adaptation to the related damage. 47-49 These positive 
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results were seen in our diabetic group, where some of the muscle damage markers 
including myoglobin concentrations, were much lower when compared to the placebo 
group.  
On the other hand, we found no significant differences between the healthy 
groups, whether they ingested the BCAA or placebo supplement. A main reason for this 
finding could be related to the fact that the supplementation duration wasn’t long enough. 
Studies have concluded that the duration of BCAA supplementation could have a large 
impact on its effects on DOMS. 78,79 For example, studies that supplemented their 
subjects over a period of 2, and 4 weeks showed significant results on lowering DOMS, 
and reducing muscle damage markers. 47,80 
An intriguing finding in our experiment was that the BCAA supplement had 
enhanced the recovery in the diabetic group, but had no effects in the healthy group. This 
difference was not likely due to a placebo effect, because all subjects were blinded to 
what supplement they were taking. A critical explanation for this occurrence could be 
attributed to the fact that diabetic individuals have a high prevalence of gastrointestinal 
complications including dyspepsia, and abdominal pain. 81,82 Diabetes mellitus is known 
to provoke many complications such as retinopathy and nephropathy, and gastrointestinal 
dysfunction is just one of these many complications. 81,83 Neuropathy and hyperglycemia 
have been found to cause abnormal gastrointestinal motility and disturbed digestion, 
which have shown to cause impaired intestinal absorption. 40-42 This may result in the 
mal-absorption of essential amino acids from the proteins in the diet of a diabetic 
individual. Thus, an amino acid supplement would be much easier for the diabetic 
individual to absorb through an impaired gastrointestinal system. 
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Suggestions for Future Research 
Several suggestions that would enhance some of the findings in this dissertation 
would be to: 
1. Look at different populations of people with diabetes, in regards to how long they 
have been diagnosed with diabetes, and whether this factor affects the intensity of 
DOMS in this population. 
2. Look at diabetic individuals who have different levels of HbA1c control, and identify 
if people with higher HbA1c, because of increased neuropathic damage, feel more or 
less soreness compared to people with lower HbA1c. 
3. Look at different durations of the supplementation, especially in the healthy control 
subjects because the BCAA supplement seemed to have minimal effects on that 
group. An extended duration might also benefit people with diabetes, where they 
might experience even less soreness with increased periods of supplementation. 
4. Look at other types of nutritional supplements, such as vitamin A, C, D, E, and Co-
Enzyme Q10, and what impact would these supplements have in regards to exercise 
performance, and reducing muscle soreness? Also, if different vitamins and 
supplements are coupled with BCAA, would this combination be even more 
beneficial in adding extra nutrients to people with diabetes, and assist in the muscle 
recovery process after exercise. 
 
Conclusion 
In this dissertation, we provided evidence that people with diabetes experienced 
higher levels of muscle soreness after an intense exercise session, when compared to 
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healthy controls. This muscle soreness was quantified non-invasively, as well as with 
invasive biomarkers. One interesting finding in this study was that we developed a new 
novel biomarker, thermal imaging, which provided an efficient and non-invasive 
technique of predicting and quantifying the extent of muscle soreness in healthy and 
diabetic individuals. This new biomarker was correlated with the pain scales, and with 
the myoglobin concentrations throughout this investigation. Thermal imaging would then 
be a painless and in-expensive way of detecting DOMS in its early stages,  
By using this biomarker and other biomarkers it was also shown that at least one 
nutritional supplement, BCAA, reduced muscle soreness and enhanced recovery in 
people with diabetes. Therefore, BCAA supplementation would be a simple method for 
stabilizing the muscle’s protein content after an acute bout of resistance exercise in 
people with diabetes. 
From this investigation we found that thermal imaging would be an early 
predictor of muscle soreness. We also concluded that BCAA would be beneficial in 
decreasing DOMS, and in enhancing muscle recovery following exercise. Thus, an acute 
dose of BCAA supplementation would help in faster muscle recovery, and an early 
detection of DOMS would assist in minimizing the incidence of injuries from over-
exercising sore muscles. 
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SUBJECT DATA COLLECTION FORM 
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The Effects of Orally Ingesting Branched Chained 
Amino Acids on Delayed Onset Muscle Soreness in 
Diabetic Patients 
 
 
Subjects Data Form: 
 
 
Subjects ID #: Gender: 
 
 
Age: Occupation: 
 
 
Height: Weight: 
 
 
BMI: Lean body weight: 
 
 
Blood pressure: Fasting blood glucose level: 
 
 
Required Weight: Required BCAA: 
 
 
Reactance: Resistance: 
 
 
Activity Level: Frame Size: 
 
 
Upper limb neuropathy testing: 
 
 
Medications or any other medical problems: 
 
 
 
 
 
Comments:
Code: 
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APPENDIX B 
SHORT FORM McGILL PAIN QUESTIONNAIRE 
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Arm: 
Pain
Arm.
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